<?xml version="1.0"?>
<!DOCTYPE rdf:RDF [
<!ENTITY DTO "http://dto.org/DTO/" >
<!ENTITY foaf "http://xmlns.com/foaf/0.1/" >
<!ENTITY life "http://www.lifekb.org/life#" >
<!ENTITY owl "http://www.w3.org/2002/07/owl#" >
<!ENTITY obo "http://purl.obolibrary.org/obo/" >
<!ENTITY xsd "http://www.w3.org/2001/XMLSchema#" >
<!ENTITY bto "http://purl.obolibrary.org/obo/bto#" >
<!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#" >
<!ENTITY dto "http://www.drugtargetontology.org/dto/" >
<!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#" >
<!ENTITY core "http://purl.obolibrary.org/obo/uberon/core#" >
<!ENTITY dc "http://purl.org/dc/elements/1.1/" >
<!ENTITY oboInOwl "http://www.geneontology.org/formats/oboInOwl#">]>
<rdf:RDF xmlns="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_domain.owl#"
	xml:base="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_domain.owl"
	xmlns:owl="http://www.w3.org/2002/07/owl#"
	xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
	xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
	xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
	xmlns:life="http://www.lifekb.org/life#"
	xmlns:core="&obo;uberon/core#"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
	xmlns:bto="&obo;bto#"
	xmlns:obo="http://purl.obolibrary.org/obo/"
	xmlns:dto="http://www.drugtargetontology.org/dto/"
	xmlns:DTO="http://dto.org/DTO/"
	xmlns:foaf="http://xmlns.com/foaf/0.1/"
	xmlns:dc="http://purl.org/dc/elements/1.1/">
	<owl:Ontology rdf:about="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_domain.owl">
		<owl:versionIRI rdf:resource="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_domain.owl"/>
		<rdfs:label>Drug Target Ontology</rdfs:label>
		<rdfs:label>DTO</rdfs:label>
		<owl:versionInfo>1.0</owl:versionInfo>
		<dc:date>2 Nov 2017</dc:date>
		<dc:contributor>Yu Lin, Saurabh Mehta, Hande Küçük- McGinty, John Paul Turner, Dusica Vidovic, Michele Forlin, Amar Koleti, Dac-Trung Nguyen, Lars Juhl Jensen, Rajarshi Guha, Stephen L. Mathias, Oleg Ursu, Vasileios Stathias, Jianbin Duan, Nooshin Nabizadeh, Caty Chung, Christopher Mader, Ubbo Visser, Jeremy J. Yang, Cristian G. Bologa, Tudor Oprea*, Stephan C. Schürer*</dc:contributor>
		<rdfs:comment xml:lang="en">contact: Stephan Schurer:  stephan dot schurer at gmail dot com</rdfs:comment>
		<dc:description>
		Drug target ontology files Drug Target Ontology (DTO) is being developed at the University of Miami in the research group of Stephan Schürer. 
		DTO is supported by grant U54CA189205 (Illuminating the Druggable Genome Knowledge Management Center, Tudor Oprea, PI) awarded by the NCI through
		the NIH Common Fund. It is a component of the Illuminating the Druggable Genome (IDG) project (https://commonfund.nih.gov/idg). The DTO project 
		develops a novel semantic framework to formalize knowledge about drug targets with a focus on the current IDG protein families. The DTO is developed
		as a reference for drug targets with the longer-term goal to create a community standard that will facilitate the integration of diverse drug discovery
		information from numerous heterogeneous resources. The first version of the DTO consists of asserted class hierarchies of the four IDG protein families,
		GPCRs, kinases, ion channels, and nuclear hormone receptors. Protein classes are linked to tissue and disease via different levels of confidence. DTO 
		also contains drug target development classifications, a large collection of cell lines from the LINCS project and relevant cell-disease and cell-tissue
		relations. DTO is modeled in OWL2-DL to enable further classification by inference reasoning and SPARQL queries. DTO is implemented following a 
		modularization approach. DTO will serve as the organizational framework for drug targets in the IDG PHAROS User Interface Portal (https://pharos.nih.gov).
		</dc:description>
		<dc:license rdf:resource="https://creativecommons.org/licenses/by-sa/4.0/"/>
	</owl:Ontology>


    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.drugtargetontology.org/dto/lincs_id -->

	<owl:AnnotationProperty rdf:about="http://www.drugtargetontology.org/dto/lincs_id"/>



    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.drugtargetontology.org/dto/DTO_61000000 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000000">
		<rdfs:label rdf:datatype="&xsd;string">kinase domain</rdfs:label>
		<obo:IAO_0000115>A structurally conserved protein domain containing the catalytic function of the kinase.</obo:IAO_0000115>
		<rdfs:isDefinedBy>https://en.wikipedia.org/wiki/Protein_kinase_domain</rdfs:isDefinedBy>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000002 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000002">
		<rdfs:label rdf:datatype="&xsd;string">AAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>AP2 associated kinase 1; AAK1; DKFZp686F03202; DKFZp686K16132; FLJ23712; FLJ25931; FLJ31060; FLJ42882; FLJ45252; KIAA1048; MGC138170; MGC164568; MGC164570</obo:IAO_0000115>
		<dto:lincs_id>200001</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000003 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000003">
		<rdfs:label rdf:datatype="&xsd;string">ABL1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000004 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000004">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(E255K) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200003</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000005 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000005">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(E255K)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000004"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200004</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000006 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000006">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317I) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000007 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000007">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317I)-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000006"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200005, 200006</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000008 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000008">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317I)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000006"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200007</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000009 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000009">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317L) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000010 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000010">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317L)-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000009"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200008, 200009</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000011 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000011">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(F317L)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000009"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200010</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000012 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000012">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(H396P) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000013 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000013">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(H396P)-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000012"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200011, 200012</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000014 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000014">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(H396P)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000012"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200013</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000015 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000015">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(M351T) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200014</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000016 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000016">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(M351T)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000015"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200015</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000017 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000017">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(Q252H) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000018 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000018">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(Q252H)-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000017"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200016, 200017</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000019 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000019">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(Q252H)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000017"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200018</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000020 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000020">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(T315I) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000021 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000021">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(T315I)-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000020"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200019, 200020</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000022 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000022">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(T315I)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000020"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200021</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000023 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000023">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(Y253F) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200022</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000024 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000024">
		<rdfs:label rdf:datatype="&xsd;string">ABL1(Y253F)-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000023"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200023</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000025 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000025">
		<rdfs:label rdf:datatype="&xsd;string">ABL1-nonphosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000003"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200002, 200024</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000026 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000026">
		<rdfs:label rdf:datatype="&xsd;string">ABL1-phosphorylated kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000003"/>
		<obo:IAO_0000115>C-abl oncogene 1, receptor tyrosine kinase; ABL; ABL1; bcr/abl; c-ABL; JTK7; p150; v-abl</obo:IAO_0000115>
		<dto:lincs_id>200025</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000027 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000027">
		<rdfs:label rdf:datatype="&xsd;string">ABL2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene); ABL2; ABLL; ARG; FLJ22224; FLJ31718; FLJ41441</obo:IAO_0000115>
		<dto:lincs_id>200026</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000028 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000028">
		<rdfs:label rdf:datatype="&xsd;string">ACVR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Activin A receptor, type I; ACTRI; ACVR1; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI</obo:IAO_0000115>
		<dto:lincs_id>200027</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000029 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000029">
		<rdfs:label rdf:datatype="&xsd;string">ACVR1B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Activin A receptor, type IB; ACTRIB; ACVR1B; ACVRLK4; ALK4; SKR2</obo:IAO_0000115>
		<dto:lincs_id>200028</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000030 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000030">
		<rdfs:label rdf:datatype="&xsd;string">ACVR2A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Activin A receptor, type IIA; ActR2; ACTRII; ACVR2; ACVR2A</obo:IAO_0000115>
		<dto:lincs_id>200029</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000031 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000031">
		<rdfs:label rdf:datatype="&xsd;string">ACVR2B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Activin A receptor, type IIB; ActR2B; ACTRIIB; ActR-IIB; ACVR2B; MGC116908</obo:IAO_0000115>
		<dto:lincs_id>200030</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000032 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000032">
		<rdfs:label rdf:datatype="&xsd;string">ACVRL1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Activin A receptor type II-like 1; ACVRL1; ACVRLK1; ALK1; ALK-1; HHT; HHT2; ORW2; SKR3; TSR-I</obo:IAO_0000115>
		<dto:lincs_id>200031</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000033 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000033">
		<rdfs:label rdf:datatype="&xsd;string">ADCK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Chaperone, ABC1 activity of bc1 complex homolog (S. pombe); ADCK3; ARCA2; CABC1; COQ8; MGC4849; SCAR9</obo:IAO_0000115>
		<dto:lincs_id>200032</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000034 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000034">
		<rdfs:label rdf:datatype="&xsd;string">ADCK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>AarF domain containing kinase 4; ADCK4; FLJ12229</obo:IAO_0000115>
		<dto:lincs_id>200033</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000035 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000035">
		<rdfs:label rdf:datatype="&xsd;string">AKT1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-akt murine thymoma viral oncogene homolog 1; AKT; AKT1; Akt1/PKBa; MGC99656; PKB; PKBa; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA</obo:IAO_0000115>
		<dto:lincs_id>200034</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000036 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000036">
		<rdfs:label rdf:datatype="&xsd;string">AKT2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-akt murine thymoma viral oncogene homolog 2; AKT2; Akt2/PKBb; PKBb; PKBBETA; PRKBB; RAC-BETA</obo:IAO_0000115>
		<dto:lincs_id>200035</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000037 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000037">
		<rdfs:label rdf:datatype="&xsd;string">AKT3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma); AKT3; Akt3/PKBg; DKFZp434N0250; PKBg; PKB-GAMMA; PRKBG; RAC-gamma; RAC-PK-gamma; STK-2</obo:IAO_0000115>
		<dto:lincs_id>200036</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000038 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000038">
		<rdfs:label rdf:datatype="&xsd;string">ALK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Anaplastic lymphoma receptor tyrosine kinase; ALK; CD246; NBLST3; TFG/ALK</obo:IAO_0000115>
		<dto:lincs_id>200037</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000039 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000039">
		<rdfs:label rdf:datatype="&xsd;string">ALK(C1156Y) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Anaplastic lymphoma receptor tyrosine kinase; ALK; CD246; NBLST3; TFG/ALK</obo:IAO_0000115>
		<dto:lincs_id>200479</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000040 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000040">
		<rdfs:label rdf:datatype="&xsd;string">ALK(L1196M) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Anaplastic lymphoma receptor tyrosine kinase; ALK; CD246; NBLST3; TFG/ALK</obo:IAO_0000115>
		<dto:lincs_id>200480</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000041 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000041">
		<rdfs:label rdf:datatype="&xsd;string">AMPK-alpha1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, AMP-activated, alpha 2 catalytic subunit; AMPK; AMPKa1; AMPK-alpha1; MGC33776; MGC57364; PRKAA1</obo:IAO_0000115>
		<dto:lincs_id>200038</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000042 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000042">
		<rdfs:label rdf:datatype="&xsd;string">AMPK-alpha2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, AMP-activated, alpha 2 catalytic subunit; AMPK; AMPK2; AMPKa2; AMPK-alpha2; PRKAA; PRKAA2</obo:IAO_0000115>
		<dto:lincs_id>200039</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000043 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000043">
		<rdfs:label rdf:datatype="&xsd;string">ANKK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ankyrin repeat and kinase domain containing 1; ANKK1; PKK2; SgK288</obo:IAO_0000115>
		<dto:lincs_id>200040</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000044 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000044">
		<rdfs:label rdf:datatype="&xsd;string">AURKA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Aurora kinase A; AIK; AIRK1; ARK1; Aur2; AURA; AurA/Aur2; AURKA; AURORA2; Aurora-A; Ayk1; BTAK; IAK; IAK1; MGC34538; STK15; STK6; STK7</obo:IAO_0000115>
		<dto:lincs_id>200044</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000045 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000045">
		<rdfs:label rdf:datatype="&xsd;string">AURKB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Aurora kinase B; AIK2; AIM1; AIM-1; ARK2; Aur1; AurB; AurB/Aur1; AURKB; aurkb-sv1; aurkb-sv2; IPL1; STK12; STK5</obo:IAO_0000115>
		<dto:lincs_id>200045</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000046 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000046">
		<rdfs:label rdf:datatype="&xsd;string">AURKC kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Aurora kinase C; AIE2; AIK3; ARK3; Aur3; AurC; AurC/Aur3; AURKC; aurora-C; STK13</obo:IAO_0000115>
		<dto:lincs_id>200046</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000047 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000047">
		<rdfs:label rdf:datatype="&xsd;string">AXL kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>AXL receptor tyrosine kinase; AXL; JTK11; UFO</obo:IAO_0000115>
		<dto:lincs_id>200047</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000048 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000048">
		<rdfs:label rdf:datatype="&xsd;string">BIKE kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>BMP2 inducible kinase; BIKE; BMP2K; DKFZp434K0614; DKFZp434P0116; HRIHFB2017</obo:IAO_0000115>
		<dto:lincs_id>200048</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000049 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000049">
		<rdfs:label rdf:datatype="&xsd;string">BLK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase BLK; B lymphoid tyrosine kinase; BLK; MGC10442</obo:IAO_0000115>
		<dto:lincs_id>200049</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000050 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000050">
		<rdfs:label rdf:datatype="&xsd;string">BMPR1A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Bone morphogenetic protein receptor, type IA; 10q23del; ACVRLK3; ALK3; BMPR1A; CD292; SKR5</obo:IAO_0000115>
		<dto:lincs_id>200050</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000051 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000051">
		<rdfs:label rdf:datatype="&xsd;string">BMPR1B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Bone morphogenetic protein receptor, type IB; ALK6; ALK-6; BMPR1B; CDw293</obo:IAO_0000115>
		<dto:lincs_id>200051</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000052 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000052">
		<rdfs:label rdf:datatype="&xsd;string">BMPR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Bone morphogenetic protein receptor, type II (serine/threonine kinase); BMPR2; BMPR3; BMPR-II; BMR2; BRK-3; FLJ41585; FLJ76945; PPH1; T-ALK</obo:IAO_0000115>
		<dto:lincs_id>200052</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000053 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000053">
		<rdfs:label rdf:datatype="&xsd;string">BMX kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>BMX non-receptor tyrosine kinase; BMX; ETK; Etk/BMX; PSCTK2; PSCTK3</obo:IAO_0000115>
		<dto:lincs_id>200053</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000054 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000054">
		<rdfs:label rdf:datatype="&xsd;string">BRAF kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase B-raf; v-raf murine sarcoma viral oncogene homolog B1; BRAF1; RAFB1</obo:IAO_0000115>
		<dto:lincs_id>200054</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000055 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000055">
		<rdfs:label rdf:datatype="&xsd;string">BRAF(V600E) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-raf murine sarcoma viral oncogene homolog B1; BRAF; BRAF1; B-RAF1; FLJ95109; MGC126806; MGC138284; RAFB1</obo:IAO_0000115>
		<dto:lincs_id>200055</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000056 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000056">
		<rdfs:label rdf:datatype="&xsd;string">BRSK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>BR serine/threonine kinase 1; BRSK1; FLJ43009; KIAA1811</obo:IAO_0000115>
		<dto:lincs_id>200057</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000057 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000057">
		<rdfs:label rdf:datatype="&xsd;string">BRSK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>BR serine/threonine kinase 2; BRSK2; C11orf7; FLJ41362; PEN11B; SAD1; STK29</obo:IAO_0000115>
		<dto:lincs_id>200058</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000058 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000058">
		<rdfs:label rdf:datatype="&xsd;string">BTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase BTK; agammaglobulinemia tyrosine kinase; AGMX1; ATK; BPK</obo:IAO_0000115>
		<dto:lincs_id>200059</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000059 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000059">
		<rdfs:label rdf:datatype="&xsd;string">BUB1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Budding uninhibited by benzimidazoles 1 homolog (yeast); BUB1A; BUB1L; hBUB1</obo:IAO_0000115>
		<dto:lincs_id>200470</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000060 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000060">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase I; CAMK1; CaMK1a; CAMKI; MGC120317; MGC120318</obo:IAO_0000115>
		<dto:lincs_id>200060</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000061 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000061">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1D kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase ID; CaM-K1; CAMK1D; CaMKID; CKLiK</obo:IAO_0000115>
		<dto:lincs_id>200061</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000062 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000062">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1G kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase IG; CAMK1G; CLICKIII; dJ272L16.1; VWS1</obo:IAO_0000115>
		<dto:lincs_id>200062</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000063 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000063">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase II alpha; CAMK2A; CAMKA; KIAA0968</obo:IAO_0000115>
		<dto:lincs_id>200063</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000064 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000064">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase II beta; CAM2; CAMK2; CAMK2B; CAMKB; MGC29528</obo:IAO_0000115>
		<dto:lincs_id>200064</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000065 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000065">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2G kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase II gamma; CAMK; CAMK2G; CAMKG; CAMK-II; FLJ16043; MGC26678</obo:IAO_0000115>
		<dto:lincs_id>200066</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000066 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000066">
		<rdfs:label rdf:datatype="&xsd;string">CAMKK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase kinase 2, beta; CAMKK; CAMKK2; CAMKKB; KIAA0787; MGC15254</obo:IAO_0000115>
		<dto:lincs_id>200069</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000067 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000067">
		<rdfs:label rdf:datatype="&xsd;string">CASK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent serine protein kinase (MAGUK family); CAGH39; CAMGUK; CASK; CMG; FGS4; FLJ22219; FLJ31914; LIN2; MICPCH; TNRC8</obo:IAO_0000115>
		<dto:lincs_id>200070</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000068 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000068">
		<rdfs:label rdf:datatype="&xsd;string">CDC2L1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 11B; CDC2L1; CDC2L2; CDK11; CDK11B; CDK11-p110; CDK11-p46; CDK11-p58; CLK-1; FLJ59152; p58; p58CDC2L1; p58CLK-1; PITSLRE; PK58</obo:IAO_0000115>
		<dto:lincs_id>200071</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000069 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000069">
		<rdfs:label rdf:datatype="&xsd;string">CDC2L2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 11A; CDC2L2; CDC2L3; CDK11A; CDK11-p110; CDK11-p46; CDK11-p58; MGC131975; p58GTA; PITSLRE</obo:IAO_0000115>
		<dto:lincs_id>200072</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000070 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000070">
		<rdfs:label rdf:datatype="&xsd;string">CDC2L5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 13; CDC2L; CDC2L5; CDK13; CHED; FLJ35215; KIAA1791</obo:IAO_0000115>
		<dto:lincs_id>200073</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000071 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000071">
		<rdfs:label rdf:datatype="&xsd;string">CDK11 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 19; bA346C16.3; CDC2L6; CDK11; CDK19; KIAA1028</obo:IAO_0000115>
		<dto:lincs_id>200074</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000072 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000072">
		<rdfs:label rdf:datatype="&xsd;string">CDK14 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 14; serine/threonine-protein kinase PFTAIRE-1; PFTK1</obo:IAO_0000115>
		<dto:lincs_id>200318</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000073 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000073">
		<rdfs:label rdf:datatype="&xsd;string">CDK15 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-Dependent Kinase 15; serine/threonine-protein kinase ALS2CR7; PFTAIRE2; PFTK2</obo:IAO_0000115>
		<dto:lincs_id>200317</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000074 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000074">
		<rdfs:label rdf:datatype="&xsd;string">CDK16 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 16; Cell division protein kinase 16; Serine/threonine-protein kinase PCTAIRE-1; FLJ16665; PCTAIRE; PCTAIRE1; PCTGAIRE; PCTK1</obo:IAO_0000115>
		<dto:lincs_id>200309</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000075 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000075">
		<rdfs:label rdf:datatype="&xsd;string">CDK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 2; p33 protein kinase</obo:IAO_0000115>
		<dto:lincs_id>200075</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000076 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000076">
		<rdfs:label rdf:datatype="&xsd;string">CDK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 3; CDK3</obo:IAO_0000115>
		<dto:lincs_id>200076</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000077 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000077">
		<rdfs:label rdf:datatype="&xsd;string">CDK4-cyclinD1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 4; cell division protein kinase 4</obo:IAO_0000115>
		<dto:lincs_id>200077</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000078 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000078">
		<rdfs:label rdf:datatype="&xsd;string">CDK4-cyclinD3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 4; cell division protein kinase 4</obo:IAO_0000115>
		<dto:lincs_id>200078</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000079 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000079">
		<rdfs:label rdf:datatype="&xsd;string">CDK5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 5; cell division protein kinase 5; PSSALRE</obo:IAO_0000115>
		<dto:lincs_id>200079</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000080 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000080">
		<rdfs:label rdf:datatype="&xsd;string">CDK7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 7; cell division protein kinase 7; CAK1; CDK7; CDKN7; MO15; p39MO15; STK1</obo:IAO_0000115>
		<dto:lincs_id>200080</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000081 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000081">
		<rdfs:label rdf:datatype="&xsd;string">CDK8 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 8; cell division protein kinase 8; CDK8; K35; MGC126074; MGC126075</obo:IAO_0000115>
		<dto:lincs_id>200081</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000082 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000082">
		<rdfs:label rdf:datatype="&xsd;string">CDK9 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 9; cell division protein kinase 9; C-2k; CDC2L4; CDK9; CTK1; PITALRE; TAK</obo:IAO_0000115>
		<dto:lincs_id>200082</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000083 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000083">
		<rdfs:label rdf:datatype="&xsd;string">CDKL1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase-like 1 (CDC2-related kinase); CDKL1; KKIALRE; P42</obo:IAO_0000115>
		<dto:lincs_id>200083</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000084 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000084">
		<rdfs:label rdf:datatype="&xsd;string">CDKL2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase-like 2 (CDC2-related kinase); CDKL2; KKIAMRE; P56</obo:IAO_0000115>
		<dto:lincs_id>200084</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000085 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000085">
		<rdfs:label rdf:datatype="&xsd;string">CDKL3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase-like 3; CDKL3; NKIAMRE</obo:IAO_0000115>
		<dto:lincs_id>200085</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000086 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000086">
		<rdfs:label rdf:datatype="&xsd;string">CDKL5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase-like 5; CDKL5; ISSX; STK9</obo:IAO_0000115>
		<dto:lincs_id>200086</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000087 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000087">
		<rdfs:label rdf:datatype="&xsd;string">CHEK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CHK1 checkpoint homolog (S. pombe); CHEK1; CHK1</obo:IAO_0000115>
		<dto:lincs_id>200087</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000088 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000088">
		<rdfs:label rdf:datatype="&xsd;string">CHK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase Chk2; CHK2 checkpoint homolog</obo:IAO_0000115>
		<dto:lincs_id>200088</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000089 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000089">
		<rdfs:label rdf:datatype="&xsd;string">CIT kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Citron (rho-interacting, serine/threonine kinase 21); CIT; CRIK; KIAA0949; STK21</obo:IAO_0000115>
		<dto:lincs_id>200089</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000090 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000090">
		<rdfs:label rdf:datatype="&xsd;string">CLK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CDC-like kinase 1; CLK; CLK/STY; CLK1; STY</obo:IAO_0000115>
		<dto:lincs_id>200090</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000091 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000091">
		<rdfs:label rdf:datatype="&xsd;string">CLK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity protein kinase CLK2; CDC-like kinase 2; CLK2; hCLK2; MGC61500</obo:IAO_0000115>
		<dto:lincs_id>200091</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000092 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000092">
		<rdfs:label rdf:datatype="&xsd;string">CLK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity protein kinase CLK3; CDC-like kinase 3; CLK3; FLJ22858; PHCLK3; PHCLK3/152</obo:IAO_0000115>
		<dto:lincs_id>200092</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000093 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000093">
		<rdfs:label rdf:datatype="&xsd;string">CLK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CDC-like kinase 4; CLK4; DKFZp686A20267</obo:IAO_0000115>
		<dto:lincs_id>200093</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000094 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000094">
		<rdfs:label rdf:datatype="&xsd;string">CSF1R kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Colony stimulating factor 1 receptor; CD115; C-FMS; CSF1R; CSF-1R; CSF-1-R; CSFR; FIM2; FIM-2; FMS; Fms/CSFR</obo:IAO_0000115>
		<dto:lincs_id>200094</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000095 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000095">
		<rdfs:label rdf:datatype="&xsd;string">CSF1R-autoinhibited kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Colony stimulating factor 1 receptor; CD115; C-FMS; CSF1R; CSF-1R; CSF-1-R; CSFR; FIM2; FIM-2; FMS; Fms/CSFR</obo:IAO_0000115>
		<dto:lincs_id>200471</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000096 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000096">
		<rdfs:label rdf:datatype="&xsd;string">CSK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-src tyrosine kinase; CSK; MGC117393</obo:IAO_0000115>
		<dto:lincs_id>200095</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000097 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000097">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1A1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 1, alpha 1; CK1; CK1a; CSNK1A1; HLCDGP1; PRO2975</obo:IAO_0000115>
		<dto:lincs_id>200096</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000098 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000098">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1A1L kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 1, alpha 1-like; CK1; CK1a2; CSNK1A1L; MGC33182</obo:IAO_0000115>
		<dto:lincs_id>200097</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000099 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000099">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1D kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 1, delta; CK1d; CSNK1D; HCKID</obo:IAO_0000115>
		<dto:lincs_id>200098</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000100 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000100">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1E kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 1, epsilon; CK1e; CSNK1E; HCKIE; MGC10398</obo:IAO_0000115>
		<dto:lincs_id>200099</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000101 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000101">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1G3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 1, gamma 3; CK1g3; CSNK1G3</obo:IAO_0000115>
		<dto:lincs_id>200102</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000102 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000102">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2A1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 2, alpha 1 polypeptide; CK2A1; CKII; CSNK2A1</obo:IAO_0000115>
		<dto:lincs_id>200103</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000103 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000103">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2A2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase 2, alpha prime polypeptide; CK2A2; CSNK2A1; CSNK2A2; FLJ43934</obo:IAO_0000115>
		<dto:lincs_id>200104</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000104 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000104">
		<rdfs:label rdf:datatype="&xsd;string">CTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Megakaryocyte-associated tyrosine kinase; CHK; CTK; DKFZp434N1212; HHYLTK; HYL; HYLTK; Lsk; MATK; MGC1708; MGC2101</obo:IAO_0000115>
		<dto:lincs_id>200105</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000105 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000105">
		<rdfs:label rdf:datatype="&xsd;string">DAPK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Death-associated protein kinase 1; DAPK; DAPK1; DKFZp781I035</obo:IAO_0000115>
		<dto:lincs_id>200106</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000106 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000106">
		<rdfs:label rdf:datatype="&xsd;string">DAPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Death-associated protein kinase 2; DAPK2; DRP1; DRP-1; MGC119312</obo:IAO_0000115>
		<dto:lincs_id>200107</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000107 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000107">
		<rdfs:label rdf:datatype="&xsd;string">DAPK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Death-associated protein kinase 3; DAPK3; FLJ36473; ZIP; ZIPK</obo:IAO_0000115>
		<dto:lincs_id>200108</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000108 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000108">
		<rdfs:label rdf:datatype="&xsd;string">DCAMKL2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Doublecortin-like kinase 2; CL2; CLICK2; CLICK-II; CLIK2; DCAMKL2; DCDC3; DCDC3B; DCK2; DCLK2; DKFZp761l032; MGC45428</obo:IAO_0000115>
		<dto:lincs_id>200110</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000109 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000109">
		<rdfs:label rdf:datatype="&xsd;string">DCAMKL3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Doublecortin-like kinase 3; CLR; DCAMKL3; DCDC3C; DCK3; DCLK3; KIAA1765</obo:IAO_0000115>
		<dto:lincs_id>200111</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000110 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000110">
		<rdfs:label rdf:datatype="&xsd;string">DCLK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase DCLK1; CL1; CLICK1; DCAMKL1; DCDC3A; DCLK; DCLK1; KIAA0369</obo:IAO_0000115>
		<dto:lincs_id>200109</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000111 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000111">
		<rdfs:label rdf:datatype="&xsd;string">DDR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Discoidin domain receptor tyrosine kinase 1; CAK; CD167; DDR; DDR1; EDDR1; HGK2; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE</obo:IAO_0000115>
		<dto:lincs_id>200112</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000112 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000112">
		<rdfs:label rdf:datatype="&xsd;string">DDR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Discoidin domain receptor tyrosine kinase 2; DDR2; MIG20a; NTRKR3; TKT; TYRO10</obo:IAO_0000115>
		<dto:lincs_id>200113</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000113 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000113">
		<rdfs:label rdf:datatype="&xsd;string">DMPK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myotonin-protein kinase; Dystrophia myotonica-protein kinase; DM; DM1; DM1PK; DMK;  MDPK; MT-PK</obo:IAO_0000115>
		<dto:lincs_id>200115</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000114 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000114">
		<rdfs:label rdf:datatype="&xsd;string">DMPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CDC42 binding protein kinase gamma (DMPK-like); CDC42BPG; DMPK2; HSMDPKIN; KAPPA-200; MRCKgamma</obo:IAO_0000115>
		<dto:lincs_id>200116</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000115 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000115">
		<rdfs:label rdf:datatype="&xsd;string">DRAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 17a; DRAK1; STK17A</obo:IAO_0000115>
		<dto:lincs_id>200117</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000116 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000116">
		<rdfs:label rdf:datatype="&xsd;string">DRAK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 17b; DRAK2; STK17B</obo:IAO_0000115>
		<dto:lincs_id>200118</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000117 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000117">
		<rdfs:label rdf:datatype="&xsd;string">DYRK1A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; DYRK; DYRK1; DYRK1A; HP86; MNB; MNBH</obo:IAO_0000115>
		<dto:lincs_id>200119</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000118 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000118">
		<rdfs:label rdf:datatype="&xsd;string">DYRK1B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B; DYRK1B; MIRK</obo:IAO_0000115>
		<dto:lincs_id>200120</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000119 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000119">
		<rdfs:label rdf:datatype="&xsd;string">DYRK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2; DYRK2; FLJ21217; FLJ21365</obo:IAO_0000115>
		<dto:lincs_id>200121</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000120 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000120">
		<rdfs:label rdf:datatype="&xsd;string">EGFR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200122</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000121 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000121">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(E746-A750del) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200123</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000122 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000122">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(G719C) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200124</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000123 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000123">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(G719S) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200125</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000124 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000124">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L747-E749del, A750P) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200126</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000125 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000125">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L747-S752del, P753S) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200127</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000126 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000126">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L747-T751del,Sins) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200128</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000127 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000127">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L858R) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200129</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000128 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000128">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L858R,T790M) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200130</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000129 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000129">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(L861Q) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200131</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000130 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000130">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(S752-I759del) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200132</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000131 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000131">
		<rdfs:label rdf:datatype="&xsd;string">EGFR(T790M) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR; ERBB; ERBB1; HER1; mENA; PIG61</obo:IAO_0000115>
		<dto:lincs_id>200133</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000132 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000132">
		<rdfs:label rdf:datatype="&xsd;string">EIF2AK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Eukaryotic translation initiation factor 2-alpha kinase 1; EIF2AK1; HCR; HRI; KIAA1369</obo:IAO_0000115>
		<dto:lincs_id>200134</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000133 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000133">
		<rdfs:label rdf:datatype="&xsd;string">EPHA1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A1; EPH; EPHA1; EPHT; EPHT1; MGC163163</obo:IAO_0000115>
		<dto:lincs_id>200135</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000134 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000134">
		<rdfs:label rdf:datatype="&xsd;string">EPHA2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A2; ARCC2; ECK; EPHA2</obo:IAO_0000115>
		<dto:lincs_id>200136</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000135 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000135">
		<rdfs:label rdf:datatype="&xsd;string">EPHA3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A3; EK4; EPHA3; ETK; ETK1; HEK; HEK4; TYRO4</obo:IAO_0000115>
		<dto:lincs_id>200137</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000136 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000136">
		<rdfs:label rdf:datatype="&xsd;string">EPHA4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A4; EPHA4; HEK8; SEK; TYRO1</obo:IAO_0000115>
		<dto:lincs_id>200138</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000137 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000137">
		<rdfs:label rdf:datatype="&xsd;string">EPHA5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A5; CEK7; EHK1; EPHA5; HEK7; TYRO4</obo:IAO_0000115>
		<dto:lincs_id>200139</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000138 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000138">
		<rdfs:label rdf:datatype="&xsd;string">EPHA6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A6; DKFZp434C1418; EPA6; EPHA6; FLJ35246; PRO57066</obo:IAO_0000115>
		<dto:lincs_id>200140</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000139 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000139">
		<rdfs:label rdf:datatype="&xsd;string">EPHA7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A7; EHK3; EPHA7; HEK11</obo:IAO_0000115>
		<dto:lincs_id>200141</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000140 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000140">
		<rdfs:label rdf:datatype="&xsd;string">EPHA8 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor A8; EEK; EK3; EPHA8; HEK3; KIAA1459</obo:IAO_0000115>
		<dto:lincs_id>200142</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000141 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000141">
		<rdfs:label rdf:datatype="&xsd;string">EPHB1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ephrin type-B receptor 1; ELK; EPHB1; EPHT2; FLJ37986; Hek6; NET</obo:IAO_0000115>
		<dto:lincs_id>200143</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000142 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000142">
		<rdfs:label rdf:datatype="&xsd;string">EPHB2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ephrin type-B receptor 2; CAPB; DRT; EK5; EPHB2; EPHT3; ERK; Hek5; MGC87492; PCBC; Tyro5</obo:IAO_0000115>
		<dto:lincs_id>200144</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000143 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000143">
		<rdfs:label rdf:datatype="&xsd;string">EPHB3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ephrin type-B receptor 3; EPHB3; ETK2; HEK2; TYRO6</obo:IAO_0000115>
		<dto:lincs_id>200145</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000144 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000144">
		<rdfs:label rdf:datatype="&xsd;string">EPHB4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ephrin type-B receptor 4; EPHB4; HTK; MYK1; TYRO11</obo:IAO_0000115>
		<dto:lincs_id>200146</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000145 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000145">
		<rdfs:label rdf:datatype="&xsd;string">EPHB6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>EPH receptor B6; EPHB6; HEP; MGC129910; MGC129911</obo:IAO_0000115>
		<dto:lincs_id>200147</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000146 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000146">
		<rdfs:label rdf:datatype="&xsd;string">ERBB2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor tyrosine-protein kinase erbB-2; CD340; ERBB2; HER2; HER-2; HER-2/neu; MLN 19; NEU; NGL; TKR1</obo:IAO_0000115>
		<dto:lincs_id>200148</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000147 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000147">
		<rdfs:label rdf:datatype="&xsd;string">ERBB3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; HER3</obo:IAO_0000115>
		<dto:lincs_id>200149</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000148 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000148">
		<rdfs:label rdf:datatype="&xsd;string">ERBB4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor tyrosine-protein kinase erbB-4; HER4; MGC138404; p180erbB4</obo:IAO_0000115>
		<dto:lincs_id>200150</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000149 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000149">
		<rdfs:label rdf:datatype="&xsd;string">ERK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 6; DKFZp686F03189; ERK3; HsT17250; MAPK6; p97MAPK; PRKM6</obo:IAO_0000115>
		<dto:lincs_id>200153</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000150 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000150">
		<rdfs:label rdf:datatype="&xsd;string">ERK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 4; ERK3; Erk4; MAPK4; p63MAPK; PRKM4</obo:IAO_0000115>
		<dto:lincs_id>200154</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000151 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000151">
		<rdfs:label rdf:datatype="&xsd;string">ERK5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 7; BMK1; ERK4; ERK5; MAPK7; PRKM7</obo:IAO_0000115>
		<dto:lincs_id>200155</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000152 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000152">
		<rdfs:label rdf:datatype="&xsd;string">ERK8 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 15; ERK7; ERK8; MAPK15</obo:IAO_0000115>
		<dto:lincs_id>200156</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000153 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000153">
		<rdfs:label rdf:datatype="&xsd;string">ERN1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Endoplasmic reticulum to nucleus signaling 1; ERN1; FLJ30999; hIRE1p; IRE1; IRE1a; IRE1P; MGC163277; MGC163279</obo:IAO_0000115>
		<dto:lincs_id>200157</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000154 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000154">
		<rdfs:label rdf:datatype="&xsd;string">FAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>PTK2 protein tyrosine kinase 2; FADK; FAK; FAK1; FRNK; pp125FAK; PTK2</obo:IAO_0000115>
		<dto:lincs_id>200158</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000155 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000155">
		<rdfs:label rdf:datatype="&xsd;string">FAK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein-tyrosine kinase 2-beta; CADTK; CAKB; FADK2; FAK2; PKB; PTK; PTK2B; PYK2; RAFTK</obo:IAO_0000115>
		<dto:lincs_id>200367</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000156 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000156">
		<rdfs:label rdf:datatype="&xsd;string">FER kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fer (fps/fes related) tyrosine kinase; FER; TYK3</obo:IAO_0000115>
		<dto:lincs_id>200159</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000157 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000157">
		<rdfs:label rdf:datatype="&xsd;string">FES kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Feline sarcoma oncogene; FES; FPS</obo:IAO_0000115>
		<dto:lincs_id>200160</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000158 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000158">
		<rdfs:label rdf:datatype="&xsd;string">FGFR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fibroblast growth factor receptor 1; BFGFR; CD331; CEK; FGFBR; FGFR1; FLG; FLJ99988; FLT2; HBGFR; KAL2; N-SAM; OGD</obo:IAO_0000115>
		<dto:lincs_id>200161</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000159 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000159">
		<rdfs:label rdf:datatype="&xsd;string">FGFR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fibroblast growth factor receptor 2; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; FGFR2; FLJ98662; JWS; KGFR; K-SAM; TK14; TK25</obo:IAO_0000115>
		<dto:lincs_id>200162</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000160 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000160">
		<rdfs:label rdf:datatype="&xsd;string">FGFR3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fibroblast growth factor receptor 3; ACH; CD333; CEK2; FGFR3; HSFGFR3EX; JTK4</obo:IAO_0000115>
		<dto:lincs_id>200163</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000161 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000161">
		<rdfs:label rdf:datatype="&xsd;string">FGFR3(G697C) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fibroblast growth factor receptor 3; ACH; CD333; CEK2; FGFR3; HSFGFR3EX; JTK4</obo:IAO_0000115>
		<dto:lincs_id>200164</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000162 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000162">
		<rdfs:label rdf:datatype="&xsd;string">FGFR4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fibroblast growth factor receptor 4; CD334; FGFR4; JTK2; MGC20292; TKF</obo:IAO_0000115>
		<dto:lincs_id>200165</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000163 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000163">
		<rdfs:label rdf:datatype="&xsd;string">FGR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog; c-fgr; c-src2; FGR; FLJ43153; MGC75096; p55c-fgr; p55-Fgr; p58c-fgr; SRC2</obo:IAO_0000115>
		<dto:lincs_id>200166</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000164 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000164">
		<rdfs:label rdf:datatype="&xsd;string">FLT3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200168</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000165 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000165">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(D835H) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200169</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000166 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000166">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(D835Y) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200170</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000167 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000167">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(ITD) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200171</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000168 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000168">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(K663Q) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200172</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000169 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000169">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(N841I) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200173</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000170 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000170">
		<rdfs:label rdf:datatype="&xsd;string">FLT3(R834Q) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200174</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000171 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000171">
		<rdfs:label rdf:datatype="&xsd;string">FLT3-autoinhibited kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 3; CD135; FLK2; FLK-2; FLT3; FLT-3; Ly72; STK1</obo:IAO_0000115>
		<dto:lincs_id>200472</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000172 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000172">
		<rdfs:label rdf:datatype="&xsd;string">FLT4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Fms-related tyrosine kinase 4; FLT4; FLT41; LMPH1A; PCL; VEGFR3</obo:IAO_0000115>
		<dto:lincs_id>200175</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000173 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000173">
		<rdfs:label rdf:datatype="&xsd;string">FRK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase FRK; Fyn-related kinase; FRK; GTK; PTK5; RAK</obo:IAO_0000115>
		<dto:lincs_id>200176</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000174 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000174">
		<rdfs:label rdf:datatype="&xsd;string">FYN kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>FYN oncogene related to SRC, FGR, YES; FYN; MGC45350; SLK; SYN</obo:IAO_0000115>
		<dto:lincs_id>200177</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000175 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000175">
		<rdfs:label rdf:datatype="&xsd;string">GAK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin G associated kinase; FLJ16629; FLJ40395; GAK; MGC99654</obo:IAO_0000115>
		<dto:lincs_id>200178</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000176 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000176">
		<rdfs:label rdf:datatype="&xsd;string">GCN2(Kin.Dom.2,S808G) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Eukaryotic translation initiation factor 2 alpha kinase 4; EIF2AK4; GCN2; KIAA1338</obo:IAO_0000115>
		<dto:lincs_id>200179</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000177 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000177">
		<rdfs:label rdf:datatype="&xsd;string">GRK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>G protein-coupled receptor kinase 1; GPRK1; GRK1; RHODK; RHODK/GRK1; RHOK; RK</obo:IAO_0000115>
		<dto:lincs_id>200180</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000178 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000178">
		<rdfs:label rdf:datatype="&xsd;string">GRK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>G protein-coupled receptor kinase 4; GPRK2L; GPRK4; GRK4; GRK4a; IT11</obo:IAO_0000115>
		<dto:lincs_id>200181</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000179 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000179">
		<rdfs:label rdf:datatype="&xsd;string">GRK7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>G protein-coupled receptor kinase 7; GPRK7; GRK7</obo:IAO_0000115>
		<dto:lincs_id>200182</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000180 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000180">
		<rdfs:label rdf:datatype="&xsd;string">GSK3A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Glycogen synthase kinase 3 alpha; DKFZp686D0638; GSK3A; GSK3alpha; GSK3-alpha</obo:IAO_0000115>
		<dto:lincs_id>200183</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000181 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000181">
		<rdfs:label rdf:datatype="&xsd;string">GSK3B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Glycogen synthase kinase 3 beta; GSK3B; GSK3beta; GSK3-beta</obo:IAO_0000115>
		<dto:lincs_id>200184</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000182 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000182">
		<rdfs:label rdf:datatype="&xsd;string">HASP kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase haspin; germ cell associated 2 (haspin); GSG2; HASPIN</obo:IAO_0000115>
		<dto:lincs_id>200473</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000183 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000183">
		<rdfs:label rdf:datatype="&xsd;string">HCK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Hemopoietic cell kinase; HCK; JTK9</obo:IAO_0000115>
		<dto:lincs_id>200185</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000184 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000184">
		<rdfs:label rdf:datatype="&xsd;string">HIPK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Homeodomain interacting protein kinase 1; HIPK1; KIAA0630; MGC26642; MGC33446; MGC33548; Myak; Nbak2</obo:IAO_0000115>
		<dto:lincs_id>200186</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000185 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000185">
		<rdfs:label rdf:datatype="&xsd;string">HIPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Homeodomain interacting protein kinase 2; DKFZp686K02111; FLJ23711; HIPK2; PRO0593</obo:IAO_0000115>
		<dto:lincs_id>200187</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000186 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000186">
		<rdfs:label rdf:datatype="&xsd;string">HIPK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Homeodomain interacting protein kinase 3; DYRK6; FIST3; HIPK3; PKY; YAK1</obo:IAO_0000115>
		<dto:lincs_id>200188</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000187 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000187">
		<rdfs:label rdf:datatype="&xsd;string">HIPK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Homeodomain interacting protein kinase 4; FLJ32818; HIPK4</obo:IAO_0000115>
		<dto:lincs_id>200189</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000188 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000188">
		<rdfs:label rdf:datatype="&xsd;string">HUNK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Hormonally up-regulated Neu-associated kinase; HUNK</obo:IAO_0000115>
		<dto:lincs_id>200191</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000189 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000189">
		<rdfs:label rdf:datatype="&xsd;string">ICK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Intestinal cell (MAK-like) kinase; ECO; ICK; KIAA0936; LCK2; MGC46090; MRK</obo:IAO_0000115>
		<dto:lincs_id>200192</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000190 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000190">
		<rdfs:label rdf:datatype="&xsd;string">IGF1R kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Insulin-like growth factor 1 receptor; CD221; IGF1R; IGFIR; IGFR; JTK13; MGC142170; MGC142172; MGC18216</obo:IAO_0000115>
		<dto:lincs_id>200193</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000191 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000191">
		<rdfs:label rdf:datatype="&xsd;string">IKKA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Inhibitor of nuclear factor kappa-B kinase subunit alpha</obo:IAO_0000115>
		<dto:lincs_id>200194</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000192 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000192">
		<rdfs:label rdf:datatype="&xsd;string">IKKB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Inhibitor of nuclear factor kappa-B kinase subunit beta</obo:IAO_0000115>
		<dto:lincs_id>200195</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000193 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000193">
		<rdfs:label rdf:datatype="&xsd;string">IKKE kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Inhibitor of nuclear factor kappa-B kinase subunit epsilon</obo:IAO_0000115>
		<dto:lincs_id>200196</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000194 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000194">
		<rdfs:label rdf:datatype="&xsd;string">INSR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Insulin receptor; CD220; HHF5; INSR; IR</obo:IAO_0000115>
		<dto:lincs_id>200197</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000195 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000195">
		<rdfs:label rdf:datatype="&xsd;string">INSRR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Insulin receptor-related receptor; INSRR; IRR</obo:IAO_0000115>
		<dto:lincs_id>200198</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000196 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000196">
		<rdfs:label rdf:datatype="&xsd;string">IRAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Interleukin-1 receptor-associated kinase 1</obo:IAO_0000115>
		<dto:lincs_id>200199</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000197 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000197">
		<rdfs:label rdf:datatype="&xsd;string">IRAK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Interleukin-1 receptor-associated kinase 3; ASRT5; FLJ13601; IRAK3; IRAKM</obo:IAO_0000115>
		<dto:lincs_id>200200</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000198 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000198">
		<rdfs:label rdf:datatype="&xsd;string">IRAK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Interleukin-1 receptor-associated kinase 4; IPD1; NY-REN-64; REN64</obo:IAO_0000115>
		<dto:lincs_id>200201</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000199 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000199">
		<rdfs:label rdf:datatype="&xsd;string">ITK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>IL2-inducible T-cell kinase; EMT; ITK; LYK; MGC126257; MGC126258; PSCTK2</obo:IAO_0000115>
		<dto:lincs_id>200202</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000200 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000200">
		<rdfs:label rdf:datatype="&xsd;string">JAK1(Kin.Dom.1) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Janus kinase 1; JAK1; JAK1~b; JAK1A; JAK1B; JAK1-pseudokinase; JTK3</obo:IAO_0000115>
		<dto:lincs_id>200203, 200205</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000201 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000201">
		<rdfs:label rdf:datatype="&xsd;string">JAK1(Kin.Dom.2) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Janus kinase 1; JAK1; JAK1~b; JAK1A; JAK1B; JAK1-pseudokinase; JTK3</obo:IAO_0000115>
		<dto:lincs_id>200204, 200206</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000202 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000202">
		<rdfs:label rdf:datatype="&xsd;string">JAK2(JH1domain-catalytic) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Janus kinase 2; JAK2; JAK2-catalytic; JTK10</obo:IAO_0000115>
		<dto:lincs_id>200207</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000203 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000203">
		<rdfs:label rdf:datatype="&xsd;string">JAK2(Kin.Dom.2) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Janus kinase 2; JAK2; JAK2-catalytic; JTK10</obo:IAO_0000115>
		<dto:lincs_id>200208</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000204 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000204">
		<rdfs:label rdf:datatype="&xsd;string">JAK3(JH1domain-catalytic) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase JAK3; Janus kinase 3; JAK-3; L-JAK</obo:IAO_0000115>
		<dto:lincs_id>200209</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000205 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000205">
		<rdfs:label rdf:datatype="&xsd;string">JAK3(Kin.Dom.2) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase JAK3; Janus kinase 3; JAK-3; L-JAK</obo:IAO_0000115>
		<dto:lincs_id>200210</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000206 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000206">
		<rdfs:label rdf:datatype="&xsd;string">JNK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 8; JNK; JNK1; JNK1A2; JNK21B1/2; MAPK8; PRKM8; SAPK1</obo:IAO_0000115>
		<dto:lincs_id>200211</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000207 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000207">
		<rdfs:label rdf:datatype="&xsd;string">JNK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 10; FLJ12099; FLJ33785; JNK3; JNK3A; MAPK10; MGC50974; p493F12; p54bSAPK; PRKM10</obo:IAO_0000115>
		<dto:lincs_id>200213</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000208 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000208">
		<rdfs:label rdf:datatype="&xsd;string">KC1G1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase I isoform gamma-1; CK1g1; CSNK1G1</obo:IAO_0000115>
		<dto:lincs_id>200100</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000209 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000209">
		<rdfs:label rdf:datatype="&xsd;string">KC1G2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Casein kinase I isoform gamma-2; Casein kinase 1, gamma 2; CK1g2; CSNK1G2</obo:IAO_0000115>
		<dto:lincs_id>200101</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000210 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000210">
		<rdfs:label rdf:datatype="&xsd;string">KCC2D kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase type II subunit delta; CaM kinase II subunit delta; CAMK2D; CAMKD; DKFZp686G23119; DKFZp686I2288; MGC44911</obo:IAO_0000115>
		<dto:lincs_id>200065</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000211 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000211">
		<rdfs:label rdf:datatype="&xsd;string">KCC4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase type IV; CAMK4; CaMK-GR; MGC36771</obo:IAO_0000115>
		<dto:lincs_id>200067</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000212 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000212">
		<rdfs:label rdf:datatype="&xsd;string">KGP1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, cGMP-dependent, type I; CGKI; cGKI-alpha; cGKI-BETA; DKFZp686K042; FLJ36117; MGC71944; PGK; PKG; PKG1; PRKG1; PRKG1B; PRKGR1B</obo:IAO_0000115>
		<dto:lincs_id>200362</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000213 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000213">
		<rdfs:label rdf:datatype="&xsd;string">KGP2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, cGMP-dependent, type II; cGKII; PKG2; PRKG2; PRKGR2</obo:IAO_0000115>
		<dto:lincs_id>200363</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000214 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000214">
		<rdfs:label rdf:datatype="&xsd;string">KIT kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200214</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000215 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000215">
		<rdfs:label rdf:datatype="&xsd;string">KIT(A829P) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200215</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000216 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000216">
		<rdfs:label rdf:datatype="&xsd;string">KIT(D816H) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200216</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000217 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000217">
		<rdfs:label rdf:datatype="&xsd;string">KIT(D816V) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200217</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000218 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000218">
		<rdfs:label rdf:datatype="&xsd;string">KIT(L576P) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200218</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000219 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000219">
		<rdfs:label rdf:datatype="&xsd;string">KIT(V559D) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200219</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000220 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000220">
		<rdfs:label rdf:datatype="&xsd;string">KIT(V559D,T670I) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200220</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000221 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000221">
		<rdfs:label rdf:datatype="&xsd;string">KIT(V559D,V654A) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200221</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000222 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000222">
		<rdfs:label rdf:datatype="&xsd;string">KIT-autoinhibited kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; C-Kit; KIT; PBT; SCFR</obo:IAO_0000115>
		<dto:lincs_id>200474</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000223 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000223">
		<rdfs:label rdf:datatype="&xsd;string">KKCC1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase kinase 1, CaM-kinase IV kinase; CAMKK1; CAMKKA; DKFZp761M0423; MGC34095</obo:IAO_0000115>
		<dto:lincs_id>200068</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000224 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000224">
		<rdfs:label rdf:datatype="&xsd;string">KPCD kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase C, delta; May1; MGC49908; nPKC-delta; PKCD; PRKCD</obo:IAO_0000115>
		<dto:lincs_id>200354</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000225 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000225">
		<rdfs:label rdf:datatype="&xsd;string">KPCD1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase D1; PKCM; PKC-MU; PKD; PKD1; PRKCM; PRKD1</obo:IAO_0000115>
		<dto:lincs_id>200359</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000226 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000226">
		<rdfs:label rdf:datatype="&xsd;string">KPCD2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase D2; HSPC187; PKD2; PRKD2</obo:IAO_0000115>
		<dto:lincs_id>200360</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000227 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000227">
		<rdfs:label rdf:datatype="&xsd;string">KPCD3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase D3; EPK2; nPKC-NU; PKC-NU; PKD3; PRKCN; PRKD3</obo:IAO_0000115>
		<dto:lincs_id>200361</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000228 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000228">
		<rdfs:label rdf:datatype="&xsd;string">KPCE kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase C, epsilon; MGC125656; MGC125657; nPKC-epsilon; PKCE; PRKCE</obo:IAO_0000115>
		<dto:lincs_id>200355</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000229 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000229">
		<rdfs:label rdf:datatype="&xsd;string">KPCI kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase C, iota; DXS1179E; MGC26534; nPKC-iota; PKCI; PRKCI</obo:IAO_0000115>
		<dto:lincs_id>200357</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000230 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000230">
		<rdfs:label rdf:datatype="&xsd;string">KPCL kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase C, eta; MGC26269; MGC5363; nPKC-eta; PKCL; PKC-L; PRKCH; PRKCL</obo:IAO_0000115>
		<dto:lincs_id>200356</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000231 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000231">
		<rdfs:label rdf:datatype="&xsd;string">KPCT kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase C theta type; MGC126514; MGC141919; nPKC-theta; PKCt; PRKCQ; PRKCT</obo:IAO_0000115>
		<dto:lincs_id>200358</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000232 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000232">
		<rdfs:label rdf:datatype="&xsd;string">LATS1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>LATS, large tumor suppressor, homolog 1 (Drosophila); LATS1; WARTS; wts</obo:IAO_0000115>
		<dto:lincs_id>200222</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000233 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000233">
		<rdfs:label rdf:datatype="&xsd;string">LATS2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>LATS, large tumor suppressor, homolog 2 (Drosophila); FLJ13161; KPM; LATS2</obo:IAO_0000115>
		<dto:lincs_id>200223</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000234 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000234">
		<rdfs:label rdf:datatype="&xsd;string">LCK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Lymphocyte-specific protein tyrosine kinase; LCK; LSK; p56lck; pp58lck; YT16</obo:IAO_0000115>
		<dto:lincs_id>200224</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000235 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000235">
		<rdfs:label rdf:datatype="&xsd;string">LIMK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>LIM domain kinase 1; LIMK</obo:IAO_0000115>
		<dto:lincs_id>200225</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000236 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000236">
		<rdfs:label rdf:datatype="&xsd;string">LIMK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>LIM domain kinase 2; LIMK2</obo:IAO_0000115>
		<dto:lincs_id>200226</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000237 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000237">
		<rdfs:label rdf:datatype="&xsd;string">LKB1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 11; LKB1; PJS; STK11</obo:IAO_0000115>
		<dto:lincs_id>200227</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000238 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000238">
		<rdfs:label rdf:datatype="&xsd;string">LOK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase 10</obo:IAO_0000115>
		<dto:lincs_id>200228</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000239 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000239">
		<rdfs:label rdf:datatype="&xsd;string">LRRK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Leucine-rich repeat serine/threonine-protein kinase 2; AURA17; DARDARIN; LRRK2; PARK8; RIPK7; ROCO2</obo:IAO_0000115>
		<dto:lincs_id>200229</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000240 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000240">
		<rdfs:label rdf:datatype="&xsd;string">LRRK2(G2019S) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Leucine-rich repeat serine/threonine-protein kinase 2; AURA17; DARDARIN; LRRK2; PARK8; RIPK7; ROCO2</obo:IAO_0000115>
		<dto:lincs_id>200230</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000241 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000241">
		<rdfs:label rdf:datatype="&xsd;string">LTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Leukocyte receptor tyrosine kinase; LTK; TYK1</obo:IAO_0000115>
		<dto:lincs_id>200231</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000242 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000242">
		<rdfs:label rdf:datatype="&xsd;string">LYN kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; FLJ26625; JTK8; LYN</obo:IAO_0000115>
		<dto:lincs_id>200232</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000243 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000243">
		<rdfs:label rdf:datatype="&xsd;string">M3K12 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 12; Dual leucine zipper bearing kinase; DLK; MAP3K12; MEKK12; MUK; ZPK; ZPKP1</obo:IAO_0000115>
		<dto:lincs_id>200114</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000244 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000244">
		<rdfs:label rdf:datatype="&xsd;string">M3K13 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 13; LZK; MAP3K13; MEKK13; MGC133196</obo:IAO_0000115>
		<dto:lincs_id>200233</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000245 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000245">
		<rdfs:label rdf:datatype="&xsd;string">M3K2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 2; MAP3K2; MEKK2; MEKK2/MAP3K2; MEKK2B</obo:IAO_0000115>
		<dto:lincs_id>200237</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000246 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000246">
		<rdfs:label rdf:datatype="&xsd;string">M3K5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 5; ASK; ASK/MAP3K5; ASK1; MAP3K5; MAPKKK5; MEKK5</obo:IAO_0000115>
		<dto:lincs_id>200042</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000247 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000247">
		<rdfs:label rdf:datatype="&xsd;string">M3K6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 6; ASK2; MAP3K6; MAPKKK6; MEKK6; MEKK6/MAP3K6; MGC125653; MGC20114</obo:IAO_0000115>
		<dto:lincs_id>200043</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000248 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000248">
		<rdfs:label rdf:datatype="&xsd;string">M4K1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase kinase 1; HPK1; MAP4K1</obo:IAO_0000115>
		<dto:lincs_id>200190</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000249 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000249">
		<rdfs:label rdf:datatype="&xsd;string">M4K3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase kinase 3; GLK; KHS2; MAP4K3; MAPKKKK3; MEKKK3; RAB8IPL1</obo:IAO_0000115>
		<dto:lincs_id>200241</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000250 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000250">
		<rdfs:label rdf:datatype="&xsd;string">MAK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Male germ cell-associated kinase; dJ417M14.2; MAK</obo:IAO_0000115>
		<dto:lincs_id>200234</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000251 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000251">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 1; MAP3K1; MAPKKK1; MEKK; MEKK1; MEKK1/MAP3K1</obo:IAO_0000115>
		<dto:lincs_id>200235</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000252 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000252">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K14 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 14; NF-kappa-beta-inducing kinase; NIK</obo:IAO_0000115>
		<dto:lincs_id>201107</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000253 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000253">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K15 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 15; bA723P2.3; FLJ16518; MAP3K15; MAP3K7</obo:IAO_0000115>
		<dto:lincs_id>200236</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000254 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000254">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 3; MAP3K3; MAPKKK3; MEKK3; MEKK3/MAP3K3</obo:IAO_0000115>
		<dto:lincs_id>200238</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000255 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000255">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 4; FLJ42439; KIAA0213; MAP3K4; MAPKKK4; MEKK4; MTK1; PRO0412</obo:IAO_0000115>
		<dto:lincs_id>200239</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000256 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000256">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase kinase 2; BL44; GCK; MAP4K2; RAB8IP</obo:IAO_0000115>
		<dto:lincs_id>200240</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000257 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000257">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase kinase 4; FLH21957; FLJ10410; FLJ20373; FLJ90111; HGK; HGK/ZC1; KIAA0687; MAP4K4; NIK; ZC1</obo:IAO_0000115>
		<dto:lincs_id>200242</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000258 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000258">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase kinase 5; GCKR; KHS; KHS1; MAP4K5; MAPKKKK5</obo:IAO_0000115>
		<dto:lincs_id>200243</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000259 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000259">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase-activated protein kinase 2; MAPKAPK2; MK2</obo:IAO_0000115>
		<dto:lincs_id>200244</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000260 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000260">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase-activated protein kinase 5; MAPKAPK5; PRAK</obo:IAO_0000115>
		<dto:lincs_id>200245</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000261 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000261">
		<rdfs:label rdf:datatype="&xsd;string">MARK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>MAP/microtubule affinity-regulating kinase 1; KIAA1477; MARK; MARK1; MGC126512; MGC126513</obo:IAO_0000115>
		<dto:lincs_id>200246</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000262 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000262">
		<rdfs:label rdf:datatype="&xsd;string">MARK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase MARK2; MAP/microtubule affinity-regulating kinase 2; EMK1; EMK-1; MGC99619; PAR-1; Par1b</obo:IAO_0000115>
		<dto:lincs_id>200247</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000263 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000263">
		<rdfs:label rdf:datatype="&xsd;string">MARK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>MAP/microtubule affinity-regulating kinase 3; CTAK1; KP78; MARK3; PAR1A</obo:IAO_0000115>
		<dto:lincs_id>200248</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000264 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000264">
		<rdfs:label rdf:datatype="&xsd;string">MARK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>MAP/microtubule affinity-regulating kinase 4; FLJ90097; KIAA1860; MARKL1; Nbla00650</obo:IAO_0000115>
		<dto:lincs_id>200249</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000265 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000265">
		<rdfs:label rdf:datatype="&xsd;string">MAST1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Microtubule associated serine/threonine kinase 1; KIAA0973; MAST1; SAST; SAST170</obo:IAO_0000115>
		<dto:lincs_id>200250</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000266 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000266">
		<rdfs:label rdf:datatype="&xsd;string">MELK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Maternal embryonic leucine zipper kinase; HPK38; KIAA0175</obo:IAO_0000115>
		<dto:lincs_id>200257</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000267 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000267">
		<rdfs:label rdf:datatype="&xsd;string">MERTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-mer proto-oncogene tyrosine kinase; c-mer; MER; MERTK; MGC133349; RP38</obo:IAO_0000115>
		<dto:lincs_id>200258</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000268 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000268">
		<rdfs:label rdf:datatype="&xsd;string">MET kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Hepatocyte growth factor receptor; AUTS9; c-Met; HGFR; MET; RCCP2</obo:IAO_0000115>
		<dto:lincs_id>200259</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000269 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000269">
		<rdfs:label rdf:datatype="&xsd;string">MET(M1250T) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Hepatocyte growth factor receptor; AUTS9; c-Met; HGFR; MET; RCCP2</obo:IAO_0000115>
		<dto:lincs_id>200260</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000270 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000270">
		<rdfs:label rdf:datatype="&xsd;string">MET(Y1235D) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Hepatocyte growth factor receptor; AUTS9; c-Met; HGFR; MET; RCCP2</obo:IAO_0000115>
		<dto:lincs_id>200261</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000271 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000271">
		<rdfs:label rdf:datatype="&xsd;string">MINK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Misshapen-like kinase 1 (zebrafish); B55; hMINK; hMINKbeta; MAP4K6; MGC21111; MINK; MINK/ZC3; MINK1; YSK2; ZC3</obo:IAO_0000115>
		<dto:lincs_id>200262</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000272 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000272">
		<rdfs:label rdf:datatype="&xsd;string">MK01 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 1; ERK; ERK2; ERT1; MAPK1; MAPK2; p38; p40; p41; p41mapk; P42MAPK; PRKM1; PRKM2</obo:IAO_0000115>
		<dto:lincs_id>200152</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000273 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000273">
		<rdfs:label rdf:datatype="&xsd;string">MK03 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 3; ERK1; HS44KDAP; HUMKER1A; MAPK3; MGC20180; P44ERK1; P44MAPK; PRKM3</obo:IAO_0000115>
		<dto:lincs_id>200151</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000274 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000274">
		<rdfs:label rdf:datatype="&xsd;string">MK09 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 9; JNK2; JNK2A; JNK2ALPHA; JNK2B; JNK2BETA; JNK-55; MAPK9; p54a; p54aSAPK; PRKM9; SAPK</obo:IAO_0000115>
		<dto:lincs_id>200212</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000275 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000275">
		<rdfs:label rdf:datatype="&xsd;string">MK11 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 11; MAPK11; p38-2; p38b; p38Beta; p38-beta; P38BETA2; PRKM11; SAPK2; SAPK2B</obo:IAO_0000115>
		<dto:lincs_id>200299</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000276 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000276">
		<rdfs:label rdf:datatype="&xsd;string">MK12 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 12; ERK3; ERK6; MAPK12; p38g; P38GAMMA; p38-gamma; PRKM12; SAPK3; SAPK-3</obo:IAO_0000115>
		<dto:lincs_id>200301</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000277 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000277">
		<rdfs:label rdf:datatype="&xsd;string">MK13 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 13; MAPK13; MGC99536; p38d; p38delta; p38-delta; PRKM13; SAPK4</obo:IAO_0000115>
		<dto:lincs_id>200300</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000278 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000278">
		<rdfs:label rdf:datatype="&xsd;string">MK14 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase 14; CSBP1; CSBP2; CSPB1; EXIP; MAPK14; Mxi2; p38; p38a; p38ALPHA; p38-alpha; PRKM14; PRKM15; RK; SAPK2A</obo:IAO_0000115>
		<dto:lincs_id>200298</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000279 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000279">
		<rdfs:label rdf:datatype="&xsd;string">MKNK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>MAP kinase interacting serine/threonine kinase 1; MKNK1; MNK1</obo:IAO_0000115>
		<dto:lincs_id>200264</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000280 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000280">
		<rdfs:label rdf:datatype="&xsd;string">MKNK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>MAP kinase interacting serine/threonine kinase 2; GPRK7; MKNK2; MNK2</obo:IAO_0000115>
		<dto:lincs_id>200265</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000281 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000281">
		<rdfs:label rdf:datatype="&xsd;string">MLCK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin light chain kinase 3; caMLCK; MGC126319; MGC126320; MLCK; MLCK2; MYLK3</obo:IAO_0000115>
		<dto:lincs_id>200266</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000282 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000282">
		<rdfs:label rdf:datatype="&xsd;string">MLK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 9; MAP3K9; MEKK9; MLK1; PRKE1</obo:IAO_0000115>
		<dto:lincs_id>200267</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000283 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000283">
		<rdfs:label rdf:datatype="&xsd;string">MLK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 10; MAP3K10; MEKK10; MLK2; MST</obo:IAO_0000115>
		<dto:lincs_id>200268</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000284 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000284">
		<rdfs:label rdf:datatype="&xsd;string">MLK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 11; MAP3K11; MEKK11; MGC17114; MLK3; MLK-3; PTK1; SPRK</obo:IAO_0000115>
		<dto:lincs_id>200269</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000285 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000285">
		<rdfs:label rdf:datatype="&xsd;string">MLTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase MLT; sterile alpha motif and leucine zipper containing kinase AZK; AZK; MLK7; mlklak; MLT; MLTK; MRK; pk; ZAK</obo:IAO_0000115>
		<dto:lincs_id>200468</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000286 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000286">
		<rdfs:label rdf:datatype="&xsd;string">MP2K1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 1; mitogen-activated protein kinase kinase 1; MAP2K1; MAPKK1; MEK1; MEK1/MAP2K1; MKK1; PRKMK1</obo:IAO_0000115>
		<dto:lincs_id>200251</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000287 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000287">
		<rdfs:label rdf:datatype="&xsd;string">MP2K2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 2; mitogen-activated protein kinase kinase 2; FLJ26075; MAP2K2; MAPKK2; MEK2; MEK2/MAP2K2; MKK2; PRKMK2</obo:IAO_0000115>
		<dto:lincs_id>200252</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000288 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000288">
		<rdfs:label rdf:datatype="&xsd;string">MP2K3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 3; mitogen-activated protein kinase kinase 3; MAP2K3; MAPKK3; MEK3; MKK3; MKK3/MAP2K3; PRKMK3</obo:IAO_0000115>
		<dto:lincs_id>200253</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000289 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000289">
		<rdfs:label rdf:datatype="&xsd;string">MP2K4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 4; mitogen-activated protein kinase kinase 4; JNKK; JNKK1; MAP2K4; MAPKK4; MEK4; MKK4; PRKMK4; SEK1; SEK1/MAP2K4; SERK1</obo:IAO_0000115>
		<dto:lincs_id>200254</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000290 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000290">
		<rdfs:label rdf:datatype="&xsd;string">MP2K5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 5; mitogen-activated protein kinase kinase 5; HsT17454; MAP2K5; MAPKK5; MEK5; PRKMK5</obo:IAO_0000115>
		<dto:lincs_id>200255</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000291 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000291">
		<rdfs:label rdf:datatype="&xsd;string">MP2K6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 6; mitogen-activated protein kinase kinase 6; MAP2K6; MAPKK6; MEK6; MKK6; MKK6/MAP2K6; PRKMK6; SAPKK3</obo:IAO_0000115>
		<dto:lincs_id>200256</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000292 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000292">
		<rdfs:label rdf:datatype="&xsd;string">MP2K7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual specificity mitogen-activated protein kinase kinase 7</obo:IAO_0000115>
		<dto:lincs_id>200263</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000293 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000293">
		<rdfs:label rdf:datatype="&xsd;string">MRCKA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CDC42 binding protein kinase alpha (DMPK-like); CDC42BPA; DKFZp686L1738; DKFZp686P1738; FLJ23347; KIAA0451; MRCK; MRCKA; PK428</obo:IAO_0000115>
		<dto:lincs_id>200270</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000294 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000294">
		<rdfs:label rdf:datatype="&xsd;string">MRCKB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>CDC42 binding protein kinase beta (DMPK-like); CDC42BPB; KIAA1124; MRCKB</obo:IAO_0000115>
		<dto:lincs_id>200271</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000295 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000295">
		<rdfs:label rdf:datatype="&xsd;string">MST1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 4; DKFZp686A2068; KRS2; MST1; STK4; YSK3</obo:IAO_0000115>
		<dto:lincs_id>200272</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000296 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000296">
		<rdfs:label rdf:datatype="&xsd;string">MST1R kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Macrophage stimulating 1 receptor (c-met-related tyrosine kinase); CD136; CDw136; MST1R; PTK8; RON</obo:IAO_0000115>
		<dto:lincs_id>200273</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000297 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000297">
		<rdfs:label rdf:datatype="&xsd;string">MST2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 3 (STE20 homolog, yeast); FLJ90748; KRS1; MST2; STK3</obo:IAO_0000115>
		<dto:lincs_id>200274</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000298 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000298">
		<rdfs:label rdf:datatype="&xsd;string">MST3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 24 (STE20 homolog, yeast); MST3; MST3B; STE20; STK24; STK3</obo:IAO_0000115>
		<dto:lincs_id>200275</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000299 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000299">
		<rdfs:label rdf:datatype="&xsd;string">MST4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine protein kinase MST4; MASK; MST4</obo:IAO_0000115>
		<dto:lincs_id>200276</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000300 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000300">
		<rdfs:label rdf:datatype="&xsd;string">MTOR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mechanistic target of rapamycin (serine/threonine kinase); FLJ44809; FRAP; FRAP1; FRAP2; MTOR; RAFT1; RAPT1</obo:IAO_0000115>
		<dto:lincs_id>200277</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000301 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000301">
		<rdfs:label rdf:datatype="&xsd;string">MUSK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Muscle, skeletal, receptor tyrosine kinase; MGC126323; MGC126324; MUSK</obo:IAO_0000115>
		<dto:lincs_id>200278</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000302 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000302">
		<rdfs:label rdf:datatype="&xsd;string">MYLK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin light chain kinase; DKFZp686I10125; FLJ12216; KRP; MLCK; MLCK1; MLCK108; MLCK210; MSTP083; MYLK; MYLK1; smMLCK</obo:IAO_0000115>
		<dto:lincs_id>200279</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000303 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000303">
		<rdfs:label rdf:datatype="&xsd;string">MYLK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin light chain kinase 2; KMLC; MLCK; MLCK2; MYLK2; skMLCK</obo:IAO_0000115>
		<dto:lincs_id>200280</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000304 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000304">
		<rdfs:label rdf:datatype="&xsd;string">MYLK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin light chain kinase family, member 4; MYLK4; SgK085</obo:IAO_0000115>
		<dto:lincs_id>200281</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000305 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000305">
		<rdfs:label rdf:datatype="&xsd;string">MYO3A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin IIIA; DFNB30; MYO3A</obo:IAO_0000115>
		<dto:lincs_id>200282</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000306 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000306">
		<rdfs:label rdf:datatype="&xsd;string">MYO3B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Myosin IIIB; MYO3B</obo:IAO_0000115>
		<dto:lincs_id>200283</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000307 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000307">
		<rdfs:label rdf:datatype="&xsd;string">NDR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 38; NDR; NDR1; STK38</obo:IAO_0000115>
		<dto:lincs_id>200284</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000308 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000308">
		<rdfs:label rdf:datatype="&xsd;string">NDR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 38 like; KIAA0965; NDR2; STK38L</obo:IAO_0000115>
		<dto:lincs_id>200285</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000309 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000309">
		<rdfs:label rdf:datatype="&xsd;string">NEK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 1; DKFZp686D06121; DKFZp686K12169; KIAA1901; MGC138800; NEK1; NY-REN-55</obo:IAO_0000115>
		<dto:lincs_id>200286</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000310 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000310">
		<rdfs:label rdf:datatype="&xsd;string">NEK10 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)- related kinase 10</obo:IAO_0000115>
		<dto:lincs_id>200481</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000311 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000311">
		<rdfs:label rdf:datatype="&xsd;string">NEK11 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 11; FLJ23495; NEK11</obo:IAO_0000115>
		<dto:lincs_id>200287</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000312 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000312">
		<rdfs:label rdf:datatype="&xsd;string">NEK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase Nek2; NIMA (never in mitosis gene a)-related kinase 2; HsPK21; NEK2; NEK2A; NLK1</obo:IAO_0000115>
		<dto:lincs_id>200288</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000313 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000313">
		<rdfs:label rdf:datatype="&xsd;string">NEK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 3; HSPK36; MGC29949; NEK3</obo:IAO_0000115>
		<dto:lincs_id>200289</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000314 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000314">
		<rdfs:label rdf:datatype="&xsd;string">NEK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 4; MGC33171; NEK4; NRK2; pp12301; STK2</obo:IAO_0000115>
		<dto:lincs_id>200290</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000315 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000315">
		<rdfs:label rdf:datatype="&xsd;string">NEK5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 5; MGC75495; NEK5</obo:IAO_0000115>
		<dto:lincs_id>200291</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000316 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000316">
		<rdfs:label rdf:datatype="&xsd;string">NEK6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 6; NEK6; SID6-1512</obo:IAO_0000115>
		<dto:lincs_id>200292</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000317 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000317">
		<rdfs:label rdf:datatype="&xsd;string">NEK7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 7; NEK7</obo:IAO_0000115>
		<dto:lincs_id>200293</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000318 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000318">
		<rdfs:label rdf:datatype="&xsd;string">NEK9 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NIMA (never in mitosis gene a)-related kinase 9; DKFZp434D0935; MGC138306; MGC16714; Nek8; NEK9; NERCC; NERCC1</obo:IAO_0000115>
		<dto:lincs_id>200294</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000319 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000319">
		<rdfs:label rdf:datatype="&xsd;string">NIM1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase NIM1; MGC42105; NIM1</obo:IAO_0000115>
		<dto:lincs_id>200295</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000320 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000320">
		<rdfs:label rdf:datatype="&xsd;string">NLK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase NLK; Nemo-like kinase; DKFZp761G1211; FLJ21033</obo:IAO_0000115>
		<dto:lincs_id>200296</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000321 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000321">
		<rdfs:label rdf:datatype="&xsd;string">NUAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NUAK family, SNF1-like kinase, 1; ARK5; KIAA0537; NUAK1</obo:IAO_0000115>
		<dto:lincs_id>200041</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000322 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000322">
		<rdfs:label rdf:datatype="&xsd;string">OSR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase OSR1; oxidative-stress responsive 1; KIAA1101; OSR1; OXSR1</obo:IAO_0000115>
		<dto:lincs_id>200297</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000323 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000323">
		<rdfs:label rdf:datatype="&xsd;string">PAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 1; MGC130000; MGC130001; PAK1; PAKalpha</obo:IAO_0000115>
		<dto:lincs_id>200302</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000324 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000324">
		<rdfs:label rdf:datatype="&xsd;string">PAK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 2; PAK2; PAK65; PAKgamma</obo:IAO_0000115>
		<dto:lincs_id>200303</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000325 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000325">
		<rdfs:label rdf:datatype="&xsd;string">PAK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 3; bPAK; CDKN1A; hPAK3; MRX30; MRX47; OPHN3; PAK3; PAK3beta</obo:IAO_0000115>
		<dto:lincs_id>200304</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000326 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000326">
		<rdfs:label rdf:datatype="&xsd;string">PAK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 4; PAK4</obo:IAO_0000115>
		<dto:lincs_id>200305</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000327 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000327">
		<rdfs:label rdf:datatype="&xsd;string">PAK6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 6; PAK5; PAK6</obo:IAO_0000115>
		<dto:lincs_id>200306</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000328 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000328">
		<rdfs:label rdf:datatype="&xsd;string">PAK7 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>P21 protein (Cdc42/Rac)-activated kinase 7; KIAA1264; MGC26232; PAK5; PAK7</obo:IAO_0000115>
		<dto:lincs_id>200307, 200308</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000329 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000329">
		<rdfs:label rdf:datatype="&xsd;string">PCTK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 17; CDK17; PCTAIRE2; PCTK2</obo:IAO_0000115>
		<dto:lincs_id>200310</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000330 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000330">
		<rdfs:label rdf:datatype="&xsd;string">PCTK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Cyclin-dependent kinase 18; CDK18; PCTAIRE; PCTAIRE3; PCTK3</obo:IAO_0000115>
		<dto:lincs_id>200311</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000331 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000331">
		<rdfs:label rdf:datatype="&xsd;string">PDPK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>3-phosphoinositide dependent protein kinase-1; MGC20087; MGC35290; PDK1; PDPK1; PRO0461</obo:IAO_0000115>
		<dto:lincs_id>200314</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000332 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000332">
		<rdfs:label rdf:datatype="&xsd;string">PFCDPK1(P.falciparum) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Calcium-dependent protein kinase 1; CDPK1; CPK; PFB0815w; PFCDPK1</obo:IAO_0000115>
		<dto:lincs_id>200315</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000333 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000333">
		<rdfs:label rdf:datatype="&xsd;string">PFPK5(P.falciparum) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein Kinase 5; cdk-related protein kinase 6; cyclin-dependent kinase; MAL13P1.279; PK5</obo:IAO_0000115>
		<dto:lincs_id>200316</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000334 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000334">
		<rdfs:label rdf:datatype="&xsd;string">PGFRA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Platelet-derived growth factor receptor, alpha polypeptide; CD140A; MGC74795; PDGFR2; PDGFR-2; PDGFRA; PDGFRalpha; PDGFR-alpha; RHEPDGFRA</obo:IAO_0000115>
		<dto:lincs_id>200312</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000335 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000335">
		<rdfs:label rdf:datatype="&xsd;string">PGFRB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Platelet-derived growth factor receptor, beta polypeptide; CD140B; JTK12; PDGFR; PDGFR1; PDGFRB; PDGFR-b; PDGFRbeta; PEGFR-beta</obo:IAO_0000115>
		<dto:lincs_id>200313</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000336 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000336">
		<rdfs:label rdf:datatype="&xsd;string">PHKG1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphorylase kinase, gamma 1 (muscle); PHKG; PHKG1</obo:IAO_0000115>
		<dto:lincs_id>200319</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000337 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000337">
		<rdfs:label rdf:datatype="&xsd;string">PHKG2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphorylase kinase, gamma 2 (testis); GSD9C; PHKG2</obo:IAO_0000115>
		<dto:lincs_id>200320</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000338 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000338">
		<rdfs:label rdf:datatype="&xsd;string">PI42C kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma; FLJ22055; PIP4K2C; PIP5K2C</obo:IAO_0000115>
		<dto:lincs_id>200343</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000339 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000339">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C2B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphoinositide-3-kinase, class 2, beta polypeptide; C2-PI3K; DKFZp686G16234; PIK3C2B</obo:IAO_0000115>
		<dto:lincs_id>200321</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000340 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000340">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C2G kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphoinositide-3-kinase, class 2, gamma polypeptide; MGC163149; PI3K-C2GAMMA; PIK3C2G</obo:IAO_0000115>
		<dto:lincs_id>200322</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000341 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000341">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200323</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000342 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000342">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(C420R) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200324</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000343 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000343">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(E542K) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200325</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000344 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000344">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(E545A) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200326</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000345 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000345">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(E545K) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200327</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000346 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000346">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(H1047L) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200328</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000347 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000347">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(H1047Y) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200329</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000348 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000348">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(I800L) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200330</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000349 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000349">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(M1043I) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200331</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000350 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000350">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA(Q546K) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; MGC142161; MGC142163; p110-alpha; PI3K; PIK3CA; PI3K-alpha</obo:IAO_0000115>
		<dto:lincs_id>200332</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000351 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000351">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta; DKFZp779K1237; MGC133043; P110BETA; PI3K; PI3KBETA; PIK3C1; PIK3CB; PI3K-beta</obo:IAO_0000115>
		<dto:lincs_id>200333</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000352 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000352">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CD kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta; p110D; P110DELTA; PI3K; PIK3CD; PI3K-delta</obo:IAO_0000115>
		<dto:lincs_id>200334</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000353 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000353">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CG kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma; PI3CG; PI3K; PI3Kgamma; PIK3; PIK3CG</obo:IAO_0000115>
		<dto:lincs_id>200335</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000354 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000354">
		<rdfs:label rdf:datatype="&xsd;string">PIK4CB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol 4-kinase, catalytic, beta; NPIK; PI4K92; PI4KB; PI4KBETA; PI4K-BETA; PI4KIIIBETA; PIK4CB</obo:IAO_0000115>
		<dto:lincs_id>200336</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000355 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000355">
		<rdfs:label rdf:datatype="&xsd;string">PIM1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Pim-1 oncogene; PIM; PIM1</obo:IAO_0000115>
		<dto:lincs_id>200337</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000356 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000356">
		<rdfs:label rdf:datatype="&xsd;string">PIM2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Pim-2 oncogene; PIM2</obo:IAO_0000115>
		<dto:lincs_id>200338</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000357 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000357">
		<rdfs:label rdf:datatype="&xsd;string">PIM3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Pim-3 oncogene; PIM3; pim-3</obo:IAO_0000115>
		<dto:lincs_id>200339</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000358 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000358">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K1A kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha; PIP5K1A</obo:IAO_0000115>
		<dto:lincs_id>200340</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000359 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000359">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K1C kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma; KIAA0589; LCCS3; PIP5K1C; PIP5Kgamma; PIP5K-GAMMA; PIPKIg_v4</obo:IAO_0000115>
		<dto:lincs_id>200341</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000360 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000360">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K2B kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Phosphatidylinositol-5-phosphate 4-kinase, type II, beta; PI5P4KB; PIP4K2B; PIP5K2B; PIP5KIIB; PIP5KIIbeta</obo:IAO_0000115>
		<dto:lincs_id>200342</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000361 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000361">
		<rdfs:label rdf:datatype="&xsd;string">PKAC-alpha kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, cAMP-dependent, catalytic, alpha; MGC102831; MGC48865; PKAa; PKACA; PKAC-a; PKACalpha; PKAC-alpha; PRKACA</obo:IAO_0000115>
		<dto:lincs_id>200344</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000362 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000362">
		<rdfs:label rdf:datatype="&xsd;string">PKAC-beta kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, cAMP-dependent, catalytic, beta; DKFZp781I2452; MGC41879; MGC9320; PKAb; PKACB; PKAC-b; PKACbeta; PKAC-beta; PRKACB</obo:IAO_0000115>
		<dto:lincs_id>200345</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000363 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000363">
		<rdfs:label rdf:datatype="&xsd;string">PKMYT1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; Protein kinase, membrane associated tyrosine/threonine 1; DKFZp547K1610; FLJ20093; MYT1</obo:IAO_0000115>
		<dto:lincs_id>200346</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000364 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000364">
		<rdfs:label rdf:datatype="&xsd;string">PKN1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase N1; DBK; MGC46204; PAK1; PAK-1; PKN; PKN1; PKN1/PRK1; PKN-ALPHA; PRK1; PRKCL1</obo:IAO_0000115>
		<dto:lincs_id>200347</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000365 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000365">
		<rdfs:label rdf:datatype="&xsd;string">PKN2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase N2; MGC150606; MGC71074; PAK2; Pak-2; PKN2; PKN2/PRK2; PRK2; PRKCL2; PRO2042</obo:IAO_0000115>
		<dto:lincs_id>200348</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000366 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000366">
		<rdfs:label rdf:datatype="&xsd;string">PKNB(M.tuberculosis) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Transmembrane Serine/Threonine-Protein Kinase B; PKNB; Protein Kinase B; STPK B</obo:IAO_0000115>
		<dto:lincs_id>200349</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000367 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000367">
		<rdfs:label rdf:datatype="&xsd;string">PLK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase PLK1; polo-like kinase 1 (Drosophila); PLK; PLK1; STPK13</obo:IAO_0000115>
		<dto:lincs_id>200350</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000368 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000368">
		<rdfs:label rdf:datatype="&xsd;string">PLK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase PLK2; polo-like kinase 2 (Drosophila); PLK2; SNK</obo:IAO_0000115>
		<dto:lincs_id>200351</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000369 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000369">
		<rdfs:label rdf:datatype="&xsd;string">PLK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase PLK3; polo-like kinase 3 (Drosophila); CNK; FNK; PLK3; PRK</obo:IAO_0000115>
		<dto:lincs_id>200352</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000370 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000370">
		<rdfs:label rdf:datatype="&xsd;string">PLK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase PLK4; polo-like kinase 4 (Drosophila); PLK4; SAK; STK18</obo:IAO_0000115>
		<dto:lincs_id>200353</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000371 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000371">
		<rdfs:label rdf:datatype="&xsd;string">PRKR kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Eukaryotic translation initiation factor 2-alpha kinase 2; EIF2AK1; EIF2AK2; MGC126524; PKR; PRKR</obo:IAO_0000115>
		<dto:lincs_id>200364</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000372 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000372">
		<rdfs:label rdf:datatype="&xsd;string">PRKX kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein kinase, X-linked; PKX1; PRKX</obo:IAO_0000115>
		<dto:lincs_id>200365</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000373 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000373">
		<rdfs:label rdf:datatype="&xsd;string">PRP4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>PRP4 pre-mRNA processing factor 4 homolog B (yeast); dJ1013A10.1; KIAA0536; PR4H; PRP4; PRP4H; PRP4K; PRPF4B</obo:IAO_0000115>
		<dto:lincs_id>200366</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000374 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000374">
		<rdfs:label rdf:datatype="&xsd;string">PTK6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Protein tyrosine kinase 6; BRK; FLJ42088; PTK6</obo:IAO_0000115>
		<dto:lincs_id>200056</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000375 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000375">
		<rdfs:label rdf:datatype="&xsd;string">RAF1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>RAF proto-oncogene serine/threonine-protein kinase; CRAF; c-Raf; NS5; RAF1; Raf-1</obo:IAO_0000115>
		<dto:lincs_id>200369</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000376 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000376">
		<rdfs:label rdf:datatype="&xsd;string">RET kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Proto-oncogene tyrosine-protein kinase receptor Ret; CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET; RET51; RET-ELE1</obo:IAO_0000115>
		<dto:lincs_id>200370</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000377 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000377">
		<rdfs:label rdf:datatype="&xsd;string">RET(M918T) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Proto-oncogene tyrosine-protein kinase receptor Ret; CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET; RET51; RET-ELE1</obo:IAO_0000115>
		<dto:lincs_id>200371</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000378 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000378">
		<rdfs:label rdf:datatype="&xsd;string">RET(V804L) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Proto-oncogene tyrosine-protein kinase receptor Ret; CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET; RET51; RET-ELE1</obo:IAO_0000115>
		<dto:lincs_id>200372</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000379 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000379">
		<rdfs:label rdf:datatype="&xsd;string">RET(V804M) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Proto-oncogene tyrosine-protein kinase receptor Ret; CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET; RET51; RET-ELE1</obo:IAO_0000115>
		<dto:lincs_id>200373</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000380 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000380">
		<rdfs:label rdf:datatype="&xsd;string">RIOK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>RIO kinase 1 (yeast); AD034; bA288G3.1; FLJ30006; MGC12903; RIOK1</obo:IAO_0000115>
		<dto:lincs_id>200374</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000381 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000381">
		<rdfs:label rdf:datatype="&xsd;string">RIOK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>RIO kinase 2 (yeast); FLJ11159; RIO2; RIOK2</obo:IAO_0000115>
		<dto:lincs_id>200375</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000382 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000382">
		<rdfs:label rdf:datatype="&xsd;string">RIOK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>RIO kinase 3 (yeast); DKFZp779L1370; RIOK3; SUDD</obo:IAO_0000115>
		<dto:lincs_id>200376</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000383 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000383">
		<rdfs:label rdf:datatype="&xsd;string">RIPK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor-interacting serine/threonine-protein kinase 1; FLJ39204; RIP; RIP1; RIPK1</obo:IAO_0000115>
		<dto:lincs_id>200377</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000384 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000384">
		<rdfs:label rdf:datatype="&xsd;string">RIPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor-interacting serine/threonine-protein kinase 2; CARD3; CARDIAK; CCK; GIG30; RICK; RIP2; RIPK2</obo:IAO_0000115>
		<dto:lincs_id>200378</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000385 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000385">
		<rdfs:label rdf:datatype="&xsd;string">RIPK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Receptor-interacting serine-threonine kinase 4; ANKK2; ANKRD3; DIK; MGC129992; MGC129993; PKK; RIP4</obo:IAO_0000115>
		<dto:lincs_id>200379</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000386 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000386">
		<rdfs:label rdf:datatype="&xsd;string">RIPK5 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Dual serine/threonine and tyrosine protein kinase; DSTYK; DustyPK; HDCMD38P; KIAA0472; RIP5; RIPK5; SgK496</obo:IAO_0000115>
		<dto:lincs_id>200380</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000387 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000387">
		<rdfs:label rdf:datatype="&xsd;string">ROCK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Rho-associated protein kinase 1; Rho-associated, coiled-coil containing protein kinase 1; MGC131603; MGC43611; P160ROCK; PRO0435; ROCK1</obo:IAO_0000115>
		<dto:lincs_id>200381</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000388 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000388">
		<rdfs:label rdf:datatype="&xsd;string">ROCK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Rho-associated protein kinase 2; Rho-associated, coiled-coil containing protein kinase 2; KIAA0619; ROCK2</obo:IAO_0000115>
		<dto:lincs_id>200382</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000389 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000389">
		<rdfs:label rdf:datatype="&xsd;string">ROS1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>C-ros oncogene 1 , receptor tyrosine kinase; c-ros-1; MCF3; ROS; ROS1</obo:IAO_0000115>
		<dto:lincs_id>200383</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000390 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000390">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA4(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 4; MSK2; RPS6KA4; RSK-B</obo:IAO_0000115>
		<dto:lincs_id>200389, 200390</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000391 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000391">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA4(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 4; MSK2; MSK2~b; RPS6KA4; RSK-B</obo:IAO_0000115>
		<dto:lincs_id>200391, 200392</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000392 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000392">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA5(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 5; MGC1911; MSK1; MSPK1; RLPK; RPS6KA5</obo:IAO_0000115>
		<dto:lincs_id>200393, 200394</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000393 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000393">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA5(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 5; MGC1911; MSK1; MSK1~b; MSPK1; RLPK; RPS6KA5</obo:IAO_0000115>
		<dto:lincs_id>200395, 200396</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000394 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000394">
		<rdfs:label rdf:datatype="&xsd;string">RSK1(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 1; HU-1; MAPKAPK1A; RPS6KA1; RSK; RSK1; RSK3</obo:IAO_0000115>
		<dto:lincs_id>200384, 200399</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000395 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000395">
		<rdfs:label rdf:datatype="&xsd;string">RSK1(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 1; HU-1; MAPKAPK1A; RPS6KA1; RSK; RSK1; RSK3</obo:IAO_0000115>
		<dto:lincs_id>200385, 200400</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000396 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000396">
		<rdfs:label rdf:datatype="&xsd;string">RSK2(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 3; CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; p90-RSK2; pp90RSK2; RPS6KA3; RSK; RSK2; S6K-alpha3</obo:IAO_0000115>
		<dto:lincs_id>200388, 200401</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000397 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000397">
		<rdfs:label rdf:datatype="&xsd;string">RSK2(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2</obo:IAO_0000115>
		<dto:lincs_id>200475</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000398 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000398">
		<rdfs:label rdf:datatype="&xsd;string">RSK3(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 2; HU-2; MAPKAPK1C; p90RSK; p90-RSK3; pp90RSK3; RPS6KA2; RSK; RSK1; RSK1/p90RSK; RSK3; S6K-alpha; S6K-alpha2</obo:IAO_0000115>
		<dto:lincs_id>200386, 200402</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000399 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000399">
		<rdfs:label rdf:datatype="&xsd;string">RSK3(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 2; HU-2; MAPKAPK1C; p90RSK; p90-RSK3; pp90RSK3; RPS6KA2; RSK; RSK1; RSK1/p90RSK; RSK3; S6K-alpha; S6K-alpha2</obo:IAO_0000115>
		<dto:lincs_id>200387, 200403</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000400 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000400">
		<rdfs:label rdf:datatype="&xsd;string">RSK4(Kin.Dom.1-N-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 90kDa, polypeptide 6; PP90RSK4; RPS6KA6; RSK4</obo:IAO_0000115>
		<dto:lincs_id>200397, 200404</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000401 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000401">
		<rdfs:label rdf:datatype="&xsd;string">RSK4(Kin.Dom.2-C-terminal) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase alpha 6; S6K-alpha-6; p90-RSK 6; pp90RSK4</obo:IAO_0000115>
		<dto:lincs_id>200398, 200405</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000402 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000402">
		<rdfs:label rdf:datatype="&xsd;string">S6K1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Ribosomal protein S6 kinase, 70kDa, polypeptide 1; p70(S6K)-alpha; p70-alpha; p70S6K; p70-S6K; PS6K; RPS6KB1; S6K; S6K1; STK14A</obo:IAO_0000115>
		<dto:lincs_id>200406</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000403 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000403">
		<rdfs:label rdf:datatype="&xsd;string">SBK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>SH3-binding domain kinase 1; Sbk; SBK1</obo:IAO_0000115>
		<dto:lincs_id>200407</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000404 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000404">
		<rdfs:label rdf:datatype="&xsd;string">SGK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase Sgk1; serum/glucocorticoid regulated kinase 1; SGK</obo:IAO_0000115>
		<dto:lincs_id>200476</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000405 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000405">
		<rdfs:label rdf:datatype="&xsd;string">SgK110 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Putative uncharacterized serine/threonine-protein kinase (Sugen kinase 110); SgK110</obo:IAO_0000115>
		<dto:lincs_id>200408</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000406 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000406">
		<rdfs:label rdf:datatype="&xsd;string">SGK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase Sgk2; Serum/glucocorticoid-regulated kinase 2</obo:IAO_0000115>
		<dto:lincs_id>201108</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000407 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000407">
		<rdfs:label rdf:datatype="&xsd;string">SGK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase Sgk3; Serum/glucocorticoid-regulated kinase 3; CISK; DKFZp781N0293; SGKL</obo:IAO_0000115>
		<dto:lincs_id>200409</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000408 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000408">
		<rdfs:label rdf:datatype="&xsd;string">SIK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase SIK1; salt-inducible kinase 1; MSK; SIK; SIK1; SNF1LK</obo:IAO_0000115>
		<dto:lincs_id>200410</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000409 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000409">
		<rdfs:label rdf:datatype="&xsd;string">SIK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase SIK2; salt-inducible kinase 2; DKFZp434K1115; KIAA0781; LOH11CR1I; QIK; SIK2; SNF1LK2</obo:IAO_0000115>
		<dto:lincs_id>200411</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000410 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000410">
		<rdfs:label rdf:datatype="&xsd;string">SIK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase SIK3; SIK family kinase 3; FLJ12240; KIAA0999; L19; QSK</obo:IAO_0000115>
		<dto:lincs_id>200368</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000411 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000411">
		<rdfs:label rdf:datatype="&xsd;string">SLK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>STE20-like serine/threonine-protein kinase; CTCL tumor antigen se20-9; bA16H23.1; KIAA0204; LOSK; MGC133067; se20-9; SLK; STK2</obo:IAO_0000115>
		<dto:lincs_id>200412</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000412 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000412">
		<rdfs:label rdf:datatype="&xsd;string">SNARK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>NUAK family, SNF1-like kinase, 2; DKFZp434J037; DKFZp686F01113; FLJ90349; NUAK2; SNARK</obo:IAO_0000115>
		<dto:lincs_id>200413</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000413 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000413">
		<rdfs:label rdf:datatype="&xsd;string">SNRK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>SNF-related serine/threonine-protein kinase; SNF1-related kinase; DKFZp779A1866; FLJ20224; HSNFRK; KIAA0096; SNRK</obo:IAO_0000115>
		<dto:lincs_id>200414</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000414 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000414">
		<rdfs:label rdf:datatype="&xsd;string">SRC kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Proto-oncogene tyrosine-protein kinase Src; V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian); ASV; c-SRC; p60-Src; SRC; SRC1</obo:IAO_0000115>
		<dto:lincs_id>200415</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000415 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000415">
		<rdfs:label rdf:datatype="&xsd;string">SRMS kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; C20orf148; dJ697K14.1; SRM; SRMS</obo:IAO_0000115>
		<dto:lincs_id>200416</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000416 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000416">
		<rdfs:label rdf:datatype="&xsd;string">SRPK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>SRSF protein kinase 1; SFRS protein kinase 1; Serine/arginine-rich protein-specific kinase 1; SFRSK1</obo:IAO_0000115>
		<dto:lincs_id>200417</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000417 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000417">
		<rdfs:label rdf:datatype="&xsd;string">SRPK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>SFRS protein kinase 2; FLJ36101; SFRSK2; SRPK2</obo:IAO_0000115>
		<dto:lincs_id>200418</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000418 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000418">
		<rdfs:label rdf:datatype="&xsd;string">SRPK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>SFRS protein kinase 3; MGC102944; MSSK1; SRPK3; STK23</obo:IAO_0000115>
		<dto:lincs_id>200419</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000419 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000419">
		<rdfs:label rdf:datatype="&xsd;string">STK16 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 16; FLJ39635; KRCT; MGC16211; MPSK; MPSK1; PKL12; STK16; TSF1</obo:IAO_0000115>
		<dto:lincs_id>200420</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000420 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000420">
		<rdfs:label rdf:datatype="&xsd;string">STK33 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 33</obo:IAO_0000115>
		<dto:lincs_id>200421</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000421 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000421">
		<rdfs:label rdf:datatype="&xsd;string">STK35 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 35; CLIK1; STK35; STK35L1</obo:IAO_0000115>
		<dto:lincs_id>200422</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000422 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000422">
		<rdfs:label rdf:datatype="&xsd;string">STK36 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 36, fused homolog (Drosophila); DKFZp434N0223; FU; Fused; KIAA1278; STK36</obo:IAO_0000115>
		<dto:lincs_id>200423</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000423 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000423">
		<rdfs:label rdf:datatype="&xsd;string">STK39 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>STE20/SPS1-related proline-alanine-rich protein kinase; serine threonine kinase 39 (STE20/SPS1 homolog, yeast); DCHT; DKFZp686K05124; PASK; SPAK; STLK3</obo:IAO_0000115>
		<dto:lincs_id>200424</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000424 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000424">
		<rdfs:label rdf:datatype="&xsd;string">SYK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase SYK; spleen tyrosine kinase; p72-Syk; DKFZp313N1010; FLJ25043; FLJ37489; SYK</obo:IAO_0000115>
		<dto:lincs_id>200425</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000425 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000425">
		<rdfs:label rdf:datatype="&xsd;string">TAK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Mitogen-activated protein kinase kinase kinase 7; MAP3K7; MEKK7; TAK1; TGF1a</obo:IAO_0000115>
		<dto:lincs_id>200426</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000426 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000426">
		<rdfs:label rdf:datatype="&xsd;string">TAOK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase TAO1; prostate-derived STE20-like kinase 2; hKFC-B; FLJ14314; KIAA1361; MAP3K16; MARKK; PSK2; TAO1; TAOK1</obo:IAO_0000115>
		<dto:lincs_id>200427</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000427 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000427">
		<rdfs:label rdf:datatype="&xsd;string">TAOK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase TAO2; prostate-derived sterile 20-like kinase 1; hKFC-C; KIAA0881; MAP3K17; PSK; PSK1; PSK1-BETA; TAO2; TAOK2</obo:IAO_0000115>
		<dto:lincs_id>200428</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000428 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000428">
		<rdfs:label rdf:datatype="&xsd;string">TAOK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase TAO3; TAO kinase 3; DKFZp666H245; DPK; FLJ31808; JIK; MAP3K18; TAO3</obo:IAO_0000115>
		<dto:lincs_id>200429</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000429 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000429">
		<rdfs:label rdf:datatype="&xsd;string">TBK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase TBK1; TANK-binding kinase 1; NF-kappa-B-activating kinase; FLJ11330; NAK; T2K; TBK1</obo:IAO_0000115>
		<dto:lincs_id>200430</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000430 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000430">
		<rdfs:label rdf:datatype="&xsd;string">TEC kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase Tec; MGC126760; MGC126762; PSCTK4; TEC</obo:IAO_0000115>
		<dto:lincs_id>200431</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000431 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000431">
		<rdfs:label rdf:datatype="&xsd;string">TESK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Testis-specific kinase 1; TESK1</obo:IAO_0000115>
		<dto:lincs_id>200432</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000432 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000432">
		<rdfs:label rdf:datatype="&xsd;string">TGFBR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Transforming growth factor, beta receptor 1; AAT5; ACVRLK4; ALK5; ALK-5; LDS1A; LDS2A; SKR4; TGFBR1; TGFR-1</obo:IAO_0000115>
		<dto:lincs_id>200433</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000433 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000433">
		<rdfs:label rdf:datatype="&xsd;string">TGFBR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Transforming growth factor, beta receptor II (70/80kDa); AAT3; FAA3; LDS1B; LDS2B; MFS2; RIIC; TAAD2; TGFbeta-RII; TGFBR2; TGFR-2</obo:IAO_0000115>
		<dto:lincs_id>200434</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000434 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000434">
		<rdfs:label rdf:datatype="&xsd;string">TIE1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase receptor Tie-1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; JTK14; TIE; TIE1</obo:IAO_0000115>
		<dto:lincs_id>200435</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000435 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000435">
		<rdfs:label rdf:datatype="&xsd;string">TIE2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Angiopoietin-1 receptor; TEK tyrosine kinase, endothelial; CD202B; TEK; TIE2; TIE-2; VMCM; VMCM1</obo:IAO_0000115>
		<dto:lincs_id>200436</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000436 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000436">
		<rdfs:label rdf:datatype="&xsd;string">TLK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase tousled-like 1; tousled-like kinase 1; KIAA0137; PKU-beta; TLK1</obo:IAO_0000115>
		<dto:lincs_id>200437</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000437 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000437">
		<rdfs:label rdf:datatype="&xsd;string">TLK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase tousled-like 2; tousled-like kinase 2; MGC44450; PKU-ALPHA; TLK2</obo:IAO_0000115>
		<dto:lincs_id>200438</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000438 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000438">
		<rdfs:label rdf:datatype="&xsd;string">TNIK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>TRAF2 and NCK interacting kinase; TNIK; TNIK/ZC2; ZC2</obo:IAO_0000115>
		<dto:lincs_id>200439</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000439 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000439">
		<rdfs:label rdf:datatype="&xsd;string">TNK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Non-receptor tyrosine-protein kinase TNK1; MGC46193; TNK1</obo:IAO_0000115>
		<dto:lincs_id>200440</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000440 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000440">
		<rdfs:label rdf:datatype="&xsd;string">TNK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine kinase, non-receptor, 2; ACK; ACK1; FLJ44758; FLJ45547; p21cdc42Hs; TNK2</obo:IAO_0000115>
		<dto:lincs_id>200441</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000441 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000441">
		<rdfs:label rdf:datatype="&xsd;string">TNNI3K kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>TNNI3 interacting kinase; CARK; HH498; MGC142099; MGC33828; TNNI3K</obo:IAO_0000115>
		<dto:lincs_id>200442</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000442 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000442">
		<rdfs:label rdf:datatype="&xsd;string">TRKA kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Neurotrophic tyrosine kinase, receptor, type 1; DKFZp781I14186; MTC; NTRK1; p140-TrkA; TRK; TRK1; TRKA; Trk-A</obo:IAO_0000115>
		<dto:lincs_id>200443</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000443 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000443">
		<rdfs:label rdf:datatype="&xsd;string">TRKB kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Neurotrophic tyrosine kinase, receptor, type 2; GP145-TrkB; NTRK2; TRKB</obo:IAO_0000115>
		<dto:lincs_id>200444</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000444 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000444">
		<rdfs:label rdf:datatype="&xsd;string">TRKC kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Neurotrophic tyrosine kinase, receptor, type 3; gp145(trkC); NTRK3; TRKC</obo:IAO_0000115>
		<dto:lincs_id>200445</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000445 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000445">
		<rdfs:label rdf:datatype="&xsd;string">TRPM6 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Transient receptor potential cation channel, subfamily M, member 6; ChaK2; HMGX; HOMG; HOMG1; HSH; TRPM6</obo:IAO_0000115>
		<dto:lincs_id>200446</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000446 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000446">
		<rdfs:label rdf:datatype="&xsd;string">TSSK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Testis-specific serine kinase 1B; FKSG81; SPOGA4; STK22D; TSSK1; TSSK1B</obo:IAO_0000115>
		<dto:lincs_id>200447</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000447 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000447">
		<rdfs:label rdf:datatype="&xsd;string">TTK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>TTK protein kinase; CT96; ESK; FLJ38280; MPS1; MPS1L1; PYT; TTK</obo:IAO_0000115>
		<dto:lincs_id>200448</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000448 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000448">
		<rdfs:label rdf:datatype="&xsd;string">TXK kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>TXK tyrosine kinase; BTKL; MGC22473; PSCTK5; PTK4; RLK; TKL; TXK</obo:IAO_0000115>
		<dto:lincs_id>200449</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000449 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000449">
		<rdfs:label rdf:datatype="&xsd;string">TYK2(JH1domain-catalytic) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Non-receptor tyrosine-protein kinase TYK2; Tyrosine kinase 2; JTK1; TYK2</obo:IAO_0000115>
		<dto:lincs_id>200450, 200452</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000450 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000450">
		<rdfs:label rdf:datatype="&xsd;string">TYK2(JH2domain-pseudokinase) kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Non-receptor tyrosine-protein kinase TYK2; Tyrosine kinase 2; JTK1; TYK2</obo:IAO_0000115>
		<dto:lincs_id>200451, 200453</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000451 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000451">
		<rdfs:label rdf:datatype="&xsd;string">TYRO3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>TYRO3 protein tyrosine kinase; BYK; Dtk; FLJ16467; RSE; Sky; Tif; TYRO3; Tyro3/Sky</obo:IAO_0000115>
		<dto:lincs_id>200454</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000452 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000452">
		<rdfs:label rdf:datatype="&xsd;string">ULK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase ULK1; Unc-51-like kinase 1 (C. elegans); ATG1; FLJ38455; FLJ46475; ULK1; UNC51; Unc51.1</obo:IAO_0000115>
		<dto:lincs_id>200455</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000453 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000453">
		<rdfs:label rdf:datatype="&xsd;string">ULK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase ULK2; Unc-51-like kinase 2 (C. elegans); KIAA0623; ULK2; Unc51.2</obo:IAO_0000115>
		<dto:lincs_id>200456</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000454 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000454">
		<rdfs:label rdf:datatype="&xsd;string">ULK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase ULK3; Unc-51-like kinase 3 (C. elegans); DKFZp434C131; FLJ90566; ULK3</obo:IAO_0000115>
		<dto:lincs_id>200457</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000455 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000455">
		<rdfs:label rdf:datatype="&xsd;string">VGFR1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Vascular endothelial growth factor receptor 1; fms-related tyrosine kinase 1; vascular permeability factor receptor; FLT; FLT1; VEGFR1</obo:IAO_0000115>
		<dto:lincs_id>200167</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000456 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000456">
		<rdfs:label rdf:datatype="&xsd;string">VGFR2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Vascular endothelial growth factor receptor 2; kinase insert domain receptor; CD309; FLK1; FLK-1; KDR; KRD-1; Ly73; VEGFR; VEGFR2; VEGFR-2</obo:IAO_0000115>
		<dto:lincs_id>200458</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000457 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000457">
		<rdfs:label rdf:datatype="&xsd;string">VRK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase VRK2; vaccinia related kinase 2; VRK2</obo:IAO_0000115>
		<dto:lincs_id>200459</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000458 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000458">
		<rdfs:label rdf:datatype="&xsd;string">WEE1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Wee1-like protein kinase; DKFZp686I18166; FLJ16446; WEE1; WEE1A; WEE1hu</obo:IAO_0000115>
		<dto:lincs_id>200460</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000459 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000459">
		<rdfs:label rdf:datatype="&xsd;string">WEE2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Wee1-like protein kinase 2; FLJ16107; WEE1B; WEE2</obo:IAO_0000115>
		<dto:lincs_id>200461</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000460 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000460">
		<rdfs:label rdf:datatype="&xsd;string">WNK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>WNK lysine deficient protein kinase 1; KDP; PSK; p65; HSN2; HSAN2; PRKWNK1</obo:IAO_0000115>
		<dto:lincs_id>200477</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000461 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000461">
		<rdfs:label rdf:datatype="&xsd;string">WNK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>WNK lysine deficient protein kinase 3; PRKWNK3</obo:IAO_0000115>
		<dto:lincs_id>200478</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000462 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000462">
		<rdfs:label rdf:datatype="&xsd;string">YANK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 32A; MGC22688; STK32A; YANK1</obo:IAO_0000115>
		<dto:lincs_id>200462</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000463 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000463">
		<rdfs:label rdf:datatype="&xsd;string">YANK2 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 32B; HSA250839; STK32; STK32B; STKG6; YANK2</obo:IAO_0000115>
		<dto:lincs_id>200463</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000464 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000464">
		<rdfs:label rdf:datatype="&xsd;string">YANK3 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine kinase 32C; MGC23665; PKE; RP11-140A10.1; STK32C; YANK3</obo:IAO_0000115>
		<dto:lincs_id>200464</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000465 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000465">
		<rdfs:label rdf:datatype="&xsd;string">YES kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase Yes; Proto-oncogene tyrosine-protein kinase Yes</obo:IAO_0000115>
		<dto:lincs_id>200465</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000466 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000466">
		<rdfs:label rdf:datatype="&xsd;string">YSK1 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Serine/threonine-protein kinase 26</obo:IAO_0000115>
		<dto:lincs_id>200466</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000467 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000467">
		<rdfs:label rdf:datatype="&xsd;string">YSK4 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>YSK4 Sps1/Ste20-related kinase homolog (S. cerevisiae); FLJ23074; MAP3K8; RCK; YSK4</obo:IAO_0000115>
		<dto:lincs_id>200467</dto:lincs_id>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_61000468 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_61000468">
		<rdfs:label rdf:datatype="&xsd;string">ZAP70 kinase domain</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_61000000"/>
		<obo:IAO_0000115>Tyrosine-protein kinase ZAP-70; Zeta-chain (TCR) associated protein kinase 70kDa; FLJ17670; FLJ17679; SRK; STD; TZK; ZAP70; ZAP-70</obo:IAO_0000115>
		<dto:lincs_id>200469</dto:lincs_id>
	</owl:Class>

</rdf:RDF>